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ABSTRACT
Sleep apnea is defined as a repetitive cessation of airflow in spite of breathing efforts. In the
middle-aged population, the prevalence of sleep apnea is 9 – 24%. Sleep apnea increases
significantly the risk of cardiovascular disease, stroke, high blood pressure, diabetes and
accidents. For example, untreated severe sleep apnea was found to increase fatal cardiovascular
events by more than 500% in a 12 year follow-up. Traditionally, overnight polysomnography
has been the primary method for diagnosing the disease and only recently have portable devices
been accepted as alternative tools for diagnostics of sleep apnea.
The aim of the first study of this work was to design, construct and evaluate a portable
device (Venla) suitable for recording of sleep apnea. In the second study, the clinical potential
of a successor (APV2) of the device developed in the first study was evaluated. The device
dependence of the reliability of an automatic analysis of sleep apnea events was investigated in
the third study. In the fourth study, a portable device (Emma) was developed for monitoring of
the level of consciousness in the intensive care unit (ICU); this device is based on recording of
auditory evoked potentials.
Technical and clinical evaluation of the novel portable monitoring devices (Venla and
APV2) revealed that they possessed similar diagnostic capabilities as a reference laboratory
instrument (Embla) in detecting sleep apnea. No statistical differences were found in the apnea
hypopnea index (AHI) or oxygen desaturation index (ODI) recorded with Venla and APV2
when compared to those recorded with the reference laboratory instrument. Furthermore, the
AHI and ODI values determined with the novel devices and the reference instrument were
highly correlated. Importantly, the novel devices showed better technical reliability, with fewer
failed recordings (Venla 6.7% and APV2 4.0%) than the widely used commercial device
(Embletta, 19.2%).
The results of the third study indicate that an exclusion of obstructive sleep apnea (OSA)
should never be done based on automated analysis alone. The diagnosis of mild OSA should
always be based on manual analysis of the recording, but if the result of the automatic analysis
is detection of moderate or severe sleep apnea, it may be accepted without further manual
confirmation of the validity of the analysis. Importantly, classifying the disease further into the
obstructive, mixed or central types should always be done manually.
In the fourth study a compact portable battery operated device for measuring event-related
potentials, somatosensory evoked potentials, as well as the electroencephalogram and
electrocardiogram was designed, constructed and programmed for off-line monitoring of the
level of consciousness or depth of sedation. The device is intended to be used in intensive care
units and emergency rooms, which places special requirements on the robustness and simplicity
of the use of the instrumentation. Technical evaluation and in vivo recordings revealed that the
device can be reliably and safely used for clinical diagnostics.
National Library of Medicine Classification: QT 36, WB 142, WF 143, WM 188, WL 341, WL
705
Medical Subject Headings: Sleep Disorders/diagnosis; Sleep Apnea Syndromes/diagnosis;
Sleep Apnea, Obstructive/diagnosis; Consciousness; Consciousness Disorders; Monitoring,
Ambulatory/instrumentation; Polysomnography; Evoked Potentials, Auditory; Electro-
encephalography; Intensive Care Units; Equipment Design; Biomedical Engineering
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CHAPTER I
Introduction
More than 70 different types of sleep disorders have been described. They are classified
into eight major categories: insomnia, sleep related breathing disorders, hypersomnias
of central origin, circadian rhythm sleep disorders, parasomnias, sleep related
movement disorders, isolated symptoms and normal variants, and other sleep disorders
(AASM 2005). The most common sleep related breathing disorders are obstructive
sleep apnea (OSA), upper airway resistance syndrome (UARS) and long lasting partial
obstruction. The most prevalent sleep disorders (with sufferers in USA presented in
brackets) are insomnia (about 60 million), sleep apnea (18 million), restless legs
syndrome (12 million) and narcolepsy (250000) (NIH 2007). This thesis concentrates
on sleep related breathing disorders, mostly on obstructive sleep apnea.
Sleep apnea is defined as a repetitive cessation of airflow in spite of breathing
efforts. A sleep apnea event can be classified into three categories (obstructive, mixed
or central) according to the strength and existence of respiratory efforts during the apnea
event. A sleep apnea patient can suffer from all types of apneas, however central apneas
are rare. In addition to apnea events, the patient can experience hypopnea events which
are classified as partial obstruction of airflow associated with decrease in blood oxygen
saturation.
In middle aged men, the estimated prevalence of sleep apnea or sleep apnea
syndrome has been reported to vary from 9 to 24% (Ancoli-Israel 1991, Young 1993,
Bearpark 1995, Marin 1997, Bixler 1998). In certain subgroups patients with
(hypertension, coronary artery disease and bariatric surgery candidates) the prevalence
is much higher (Andreas 1996, Worsnop 1998, Gottlieb 1999, Frey 2003, O'Keeffe
2004, Valham 2008). For example, O’Keeffe (2004) found that 77% of candidates for
bariatric surgery suffered from sleep apnea. There are many risk factors for obstructive
sleep apnea, the most common of which include being overweight, a male, and having a
family history of the disease. Sleep apnea has several undesirable consequences but the
cardiovascular sequelae are the most serious (Wilcox 1998, Shahar 2001, Marin 2005,
Valham 2008). Marin (2005) reported that untreated severe sleep apnea increased the
risk of fatal cardiovascular events by more than 500% during a 12 year follow-up.
Portable monitoring (PM) or respiratory polygraphy (RP) has recently been
accepted as an alternative to overnight polysomnography (PSG) (Thurnheer 2007) for
the evaluation of suspected obstructive sleep apnea. It has been reported in a number of
papers that the PM is appropriate for the recording of sleep apnea (Whittle 1997,
Ballester 2000, Portier 2000, Lloberes 2001, Gagnadoux 2002, Dingli 2003, Douglas
2003, Ahmed 2007, Collop 2008a, Collop 2008b, Kayyali 2008). Portable monitoring
has several advantages: increased accessibility, better patient acceptance, convenience
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of home recording, low cost and applicability to telemedicine. However, it also has
several disadvantages including potential for data loss, misinterpretation of the results
due to limited data such as misinterpretation of wake time as sleep, and for
inappropriate use of automatic scoring (Douglas 2003, Collop 2009). Unfortunately, the
proportion of unsuccessful PM recordings with current commercial ambulatory devices
has been reported to be rather high (5.6 to 23.4%) (Whittle 1997, Portier 2000,
Gagnadoux 2002, Dingli 2003). This causes unnecessary lengthening of queuing times
and an increase in costs.
The main objective of Study I of this thesis was to design, construct and evaluate a
compact, technically reliable and easy-to-use eight-channel recording device suitable for
clinical use in hospital and at home. The objective of Study II was to evaluate a new
commercial PM device for home recordings and to estimate its potential for telemedical
applications. The aim of Study III was to investigate the reliability of automatic analysis
of sleep apnea events compared to manual analysis of the same data.
Many conditions can cause altered consciousness or coma (e.g. head injury, heart
disease, diabetes, sedatives or other drugs) (Posner 2007). Monitoring the level of
consciousness or depth of sedation is essential in modern intensive care units and
emergency rooms (Jordan 1999). Traditionally, electroencephalography (EEG) has been
used to gather information on the state of the brain. However, conventional EEG is
merely a passive method for recording the resting or background state of the brain.
Somatosensory, auditory and visual evoked potentials have been used to collect
additional information on the responses of the brain to sensory stimuli. In particular,
long latency auditory evoked potential measurements appear to hold promise for
evaluation of cortical functions and the depth of sedation or coma (Yppärilä 2002a,
Yppärilä 2002b, Haenggi 2004, Yppärilä 2004a, Yppärilä 2004b). However, despite the
clear diagnostic potential for recording of event-related potentials (ERPs) in the
intensive care unit (ICU) no portable devices for this purpose exist.
For this reason, the aim of Study IV was to design, construct and evaluate a
compact, technically reliable, battery-operated, auditory ERP device suitable for use in
the ICU.
In summary, the four main aims of this thesis are 1) to develop and evaluate a
portable monitoring device for recording of sleep apnea, 2) to evaluate the clinical
potential of its successor, 3) to investigate the reliability of automatic analysis of sleep
apnea events and 4) to develop a portable device for evaluating the level of
consciousness with auditory evoked potentials.
Kuopio University Publications C. Natural and Environmental Sciences 261: 1 - 79 (2009)
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CHAPTER II
Sleep apnea
A sleep apnea event is defined as a total respiratory cessation lasting longer than 10
seconds during sleep. A hypopnea event is defined as a reduction of respiratory air flow
associated with a desaturation event. Obstructive sleep apnea is characterized by
repetitive episodes of upper airway obstruction that occur during sleep. Apnea events
having an initial central component followed by an obstructive component are called
mixed apnea events (AASM 2005, AASM 2007). Sleep apnea syndrome (SAS, i.e.
sleep apnea combined with daytime sleepiness due to nocturnal respiratory arrest or
repeated nocturnal awakening) has been reported to increase the risk of car accidents,
cardiovascular diseases, stroke, hypertension, even death. Milder consequences may
include excessive daytime sleepiness, psychological problems and a reduction in the
quality of life.
2.1 Symptoms and prevalence of sleep apnea
Typical symptoms of sleep apnea are snoring, choking and gasping. A significant
relationship between snoring and sleep apnea has been detected (Viner 1991, Flemons
1994, Maislin 1995, Netzer 1999, Duran 2001, Young 2002). However, the high
prevalence of snoring without sleep apnea in the general population makes it an
unreliable indicator of sleep apnea. Witnessed apneas or bed partner’s reports of
choking or gasping are important preliminary information for use in the diagnostics.
The estimates of the prevalence of witnessed apneas in the general adult population vary
from 3.8% to 6% (Ohayon 1997, Duran 2001, Teculescu 2005). However, the
diagnostic gain from witnessed apneas is limited by the facts that not everyone has a
bed partner and that people may be poor reporters of abnormal respiratory events
(Haponik 1984).
The prevalence of obstructive sleep apnea is high and comparable to that of several
other important chronic diseases such as asthma, chronic obstructive pulmonary disease,
type 2 diabetes and coronary artery disease (AHA 1994). In a population study
conducted in Wisconsin, the prevalence of moderate or severe OSA in middle-aged (age
30 – 60 years) men was 24% compared to 9% for women (Young 1993), (Table 2.1).
Similar estimates have been reported in several studies (Lavie 1983, Duran 2001, Ip
2001). The prevalence of sleep apnea is significantly age-dependent (Ancoli-Israel
1991). Bixler (1998) found that the prevalences of sleep apnea in men in age groups of
20 – 29, 30 – 39, 40 – 49 and 50 – 59 years were 0.4%, 1.5%, 2.8% and 5.4%,
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respectively. The prevalence was found to decrease in the groups of 60 to 69 years and
 70 years (4.2% and 2.5%, respectively) (Bixler 1998).
The prevalence of sleep apnea has been shown to be strikingly high in certain
patient subgroups (Table 2.2). In individuals suffering from hypertension, values in the
range 30 to 40% have been found (Worsnop 1998, Kryger 2005). In middle-aged adults
with drug-resistant hypertension, the prevalence of OSA may be even greater than 80%
(Logan 2001). Patients with coronary artery disease display a high prevalence (50%) of
OSA (Andreas 1996). Central, obstructive, and mixed patterns of sleep apnea are
commonly observed in hypothyroidism (VanDyck 1989).
Table 2.1: The prevalence of sleep apnea in the normal population.
Group Age (years) Criterion Patients Prevalence (%) Reference
Wisconsin 30 - 60 AHI  5 Men 24 (Young 1993)
30 - 60 AHI  5 Women 9
30 - 60 Moderate Men 9
30 - 60 Moderate Women 4
Pennsylvania 20 - 100 AHI  10 Men 3.3 (Bixler 1998)
50 - 59 AHI  10 Men 5.4
Zaragoza 18 - 86 ODI  10 Men 2.2 (Marin 1997)
18 - 88 ODI  10 Women 0.8
Busselton 40 - 65 RDI  10 Men 10 (Bearpark 1995)
San Diego  65 AI  5 Men+Women 24 (Ancoli-Israel 1991)
 65 RDI  10 Men+Women 65
AHI (apnea-hypopnea index) is the number of apnea or hypopnea events per hour of sleep
ODI (oxygen desaturation index) is the number of oxygen desaturation events per hour of sleep
AI (apnea index) is the number of apnea events per hour of sleep
RDI (respiratory disturbance index) is similar to the AHI, however, it also includes respiratory events that
do not technically meet the definitions of apneas or hypopneas, but do disrupt sleep
2.2 Risk factors of obstructive sleep apnea
The etiology of sleep apnea is not fully understood (Deegan 1995, McNicholas 1998)
and the role of obesity is somewhat unclear (McNicholas 1998, Vgontzas 2000). One
theory suggests that the development of sleep apnea is caused by enlargement of soft
tissues surrounding the upper airway, increasing the risk of airway collapse during sleep
(Billington 2002). At least 60 to 70% of patients with obstructive sleep apnea are obese
(Millman 1991). In particular, visceral fat increases the risk of sleep apnea (Shinohara
1997). A large neck circumference is a clear indicator of central obesity and a major risk
factor of OSA (Davies 1992, Mortimore 1998). It has been reported that a ten percent
increase in weight is associated with a 32% increase in AHI, whereas a ten percent
weight loss decreases AHI by 26% (Peppard 2000). Males have a higher risk of OSA
than females (Schwab 1999). There is also a racial component; African-Americans and
Asians have a greater risk for OSA than Caucasians (Ancoli-Israel 1995, Redline 1997,
Li 1999).
Several studies have demonstrated that there is family aggregation of OSA pointing
to the importance of genetic factors in disease development (Pillar 1995, Redline 1995).
The heritability of the propensity for OSA has been found to range from 30% to 35%
(Palmer 2003, Carmelli 2004). Nasal obstruction during sleep (Carskadon 1997),
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2 Sleep Apnea
alcohol intake before sleep (Mitler 1988) and habitual smoking (Wetter 1994, Kashyap
2001) are clear risk factors of OSA (Table 2.3). Other risk factors include
hypothyroidism, acromegaly, use of benzodiazepines or other relaxants, upper airway
structural abnormalities (such as large tonsils) and use of exogenous testosterone (Al
Lawati 2009).
Table 2.2: The prevalence of sleep apnea in patients suffering from cardiovascular diseases,
hypertension or obesity.
Group Age (years) Criterion Patients Prevalence (%) Reference
Cardiovascular
diseases
65  11 RDI  5 Men+Women 51 (Gottlieb 1999)
Hypertension 58 mean AHI  5 Mostly men 38 (Worsnop 1998)
Coronary artery
disease
61 6 AHI  10 Men+Women 50 (Andreas 1996)
Coronary artery
disease
59.9 7.4 AHI  5 Men+Women 54 (Valham 2008)
Bariatric surgery 19 - 60 AHI  5 Mostly women 71 (Frey 2003)
Bariatric surgery 20 - 72 AHI  5 Mostly women 77 (O'Keeffe 2004)
Table 2.3: The most common risk factors of obstructive sleep apnea and their relative strength
as estimated by the author on the basis of the literature.
Risk factor Relative risk References
Visceral fat **** (Shinohara 1997, Vgontzas 2000)
Neck circumference *** (Davies 1992, Mortimore 1998)
Obesity *** (Peppard 2000)
Male sex ** (Schwab 1999)
Negroid or mongoloid race ** (Redline 1997, Li 1999)
Genetics ** (Pillar 1995, Redline 1995)
Nasal obstruction during sleep ** (Carskadon 1997)
Alcohol intake before sleep ** (Mitler 1988)
Muscle relaxants ** (Al Lawati 2009)
Large tonsils ** (Al Lawati 2009)
Habitual smoking * (Wetter 1994, Kashyap 2001)
Hypothyroidism * (Al Lawati 2009)
Acromegaly * (Al Lawati 2009)
2.3 Consequences of sleep apnea
Heavy snoring, morning headache, interrupted nocturnal sleep and excessive
daytime sleepiness are common symptoms of OSA. Excessive daytime sleepiness
(ESD) may cause serious accidents in tasks demanding continuous alertness (e.g., car
driving). Several studies have shown that sleep apnea has serious cardiovascular
consequences (Wilcox 1998, Shahar 2001, Marin 2005, Valham 2008) (Table 2.4). In
men, severe OSA increases significantly the risk of fatal and non-fatal cardiovascular
events (Marin 2005), (Figure 2.1).
Epidemiological studies (Young 1993, Duran 2001, Bixler 2005) estimate the
prevalence of EDS to range from 8% to 30% in the general population. EDS itself is not
necessarily a sign of sleep apnea, because there are several underlying etiologies for
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EDS. Furthermore, it is important to note that people often underestimate their
sleepiness (Engleman 1997).
Table 2.4: The strength of connection between obstructive sleep apnea and its various
consequences as estimated by the author on the basis of the literature.
Consequence Strength of
connection to OSA
Reference
Morning headaches **** (Ulfberg 1996, Alberti 2005)
Hypertension *** (Wilcox 1998, Nieto 2000)
Cardiovascular disease *** (Wilcox 1998, Shahar 2001, Marin 2005)
Stroke ** (Valham 2008)
Traffic accidents ** (George 1999, Teran-Santos 1999)
Autonomic instability * (Shepard 1992, Kansanen 1998, Salo 2000)
The Epworth sleepiness scale (ESS) has been introduced as a method to identify and
quantify the symptoms of sleep apnea (Johns 1991). The ESS scale extends from 0 to
24. The normal range is from 2 to 10, and apnea patients have scores from 4 to 24.
Although the ESS score has been shown to discern patient groups with different
severities of the disease, it does not provide reliable information on the severity of the
disease in a single individual (Gottlieb 1999).
In a recent study, sleep apnea was found to be associated (independently of other
risk factors) with an almost tripled risk of stroke (Valham 2008). In addition, autonomic
instability and hypertension have been found to be related to sleep apnea (Shepard
1992, Kansanen 1998, Salo 2000).
Figure 2.1: The cumulative percentage of individuals with new fatal and non-fatal
cardiovascular (CVS) events in controls, mild and severe OSA patients. Figure redrawn from the
study of Marin (2005).
2.4 Laboratory diagnostics of obstructive sleep apnea
2.4.1 Clinical diagnosis of sleep apnea syndrome
There are more than 70 different types of sleep disorders (AASM 2005) and
differentiating between these disorders requires well-defined diagnostic criteria. If a
sleep disorder is not explained by a medical or neurological disorder or by medication
or substance use, the disorder in question may be obstructive sleep apnea. Complaints of
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2 Sleep Apnea
daytime sleepiness and bed partner’s reports of loud snoring and breathing interruptions
may represent an indicator of OSA. In polysomnography more than five apneas or
hypopneas per hour of sleep is an indication of sleep apnea. The diagnostic criteria of
obstructive sleep apnea syndrome (OSAS) in adults set by the American Academy of
Sleep Medicine (AASM) are presented in Figure 2.2 (AASM 2005).
The severity of sleep apnea can be divided into three classes (Nieto 2000). The
dividing line between normal and OSA is five apneas and / or hypopneas per hour of
sleep (AHI). OSA is mild if the number of apneas and hypopneas per hour of sleep is
equal or greater than five and smaller than 15. The disorder is severe if AHI is greater
than 30. The moderate category is located between the mild and severe categories. The
severity limits are shown in Table 2.5. According to the Finnish national guidelines, the
limit between mild and moderate is 16 instead of 15. In this work, the Finnish national
limits have been used. Despite published recommendations (Nieto 2000), the diagnostic
criteria of OSA vary from sleep laboratory to sleep laboratory. For example, in some
studies, an AHI of ten has been used as the value differentiating normal subjects from
OSA patients (Ancoli-Israel 1991, Bearpark 1995, Marin 1997, Bixler 1998).
Figure 2.2: The diagnostic criteria of obstructive sleep apnea syndrome in adults (AASM 2005).
The RERA is a respiratory effort-related arousal.
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Table 2.5: The severity limits of the sleep apnea in adults (Nieto 2000).
Severity of the sleep apnea Limits of the AHI-values
Normal AHI < 5
Mild 5  AHI < 15
Moderate 15  AHI < 30
Severe 30  AHI
Previously, overnight laboratory polysomnography including EEG has been the only
acceptable diagnostic method for evaluation of suspected obstructive sleep apnea.
However, portable monitoring or respiratory polygraphy has now become an acceptable
alternative (Thurnheer 2007), and the AASM has published clinical practice guidelines
to help clinicians in the use of PM (Collop 2007). The monitoring devices can be
classified into four different types (Ferber 1994) (Table 2.6).
Table 2.6: The classification (Ferber 1994) and advantages and disadvantages (Collop 2009) of
devices designed for the diagnostics of sleep apnea.
Type Signals Site Attendance Advantages Disadvantages
1 All * Sleep
laboratory
Yes Best method, Reference
for the others
Expensive, Difficult
to access, Laborious
2 Similar to Type 1
except video and
audio
Ward,
Home
No Can be used at home Expensive devices,
Laborious
3 Airflow,
Respiratory
movements,
SpO2, HR,
Snoring, Body
position,
Movement
Ward,
Home
No Can be used at home,
Rapid installation,
Moderate costs,
Reasonably easy to
analyse
Unable to determine
sleep stages or
continuity, May
underestimate UARS,
RDI or AHI
4 Oxygen
saturation,
Airflow
Home No As in Type 3, Low
cost, Simple to use
As in Type 3 plus
additional limitations
* Depending on the laboratory, a large number of signals (EEG, EOG (electrooculogram), EMG
(electromyogram), ECG (electrocardiogram), SpO2 (oxygen saturation), CO2 (carbon dioxide), Airflow,
Respiratory movements, HR (heart rate), Snoring, Body position, Movement, etc.) together with Video
and Audio may be recorded.
PM has several advantages: increased accessibility, patient acceptance, convenience
of home recording, low cost and applicability to telemedicine. However, it also has
several disadvantages including potential data loss, risk of misinterpretation of the
results due to limited data such as misinterpretation of wake time as sleep, and
possibility for inappropriate use of automatic scoring (Douglas 2003, Collop 2009)
(Table 2.7).
Pioneering work for portable monitoring was done in the late 1980s (Penzel 1990).
Since then, numerous portable monitor studies have been performed to evaluate the
ability of PM to record sleep apnea (Whittle 1997, Ballester 2000, Portier 2000,
Lloberes 2001, Gagnadoux 2002, Dingli 2003, Douglas 2003, Ahmed 2007, Collop
2008a, Collop 2008b, Kayyali 2008). In addition, two recent studies, which
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concentrated on the outcomes of treatment of obstructive sleep apnea, have
demonstrated that in comparison to polysomnography, portable monitoring could
effectively diagnose patients with OSA (Whitelaw 2005, Mulgrew 2007).
Table 2.7: The advantages and disadvantages of PM in diagnostics of OSA (Collop 2009).
Advantages
Increased accessibility
Patient acceptance
May be done in the home
Convenience
Relatively low costs
Disadvantages
Absence of a trained technician to correct artefacts and make equipment adjustments, sensor failures
Inability to intervene in medically unstable patients
Potential data loss or distortion
Potential misinterpretation of the results due to limited data
Inability to perform subsequent multiple sleep latency testing according to the standard protocol
Varied sensor technology
No measurement of sleep
2.4.2 Methods for recording of sleep apnea
Sensitivity, specificity, reproducibility and patient safety are important general criteria
for any sensor for monitoring respiration (Johansson 2004). Small size, minimal
interference and obstruction, rapid response, and low cost are also desirable features.
Type 3 PM devices do not contain channels and transducers for recording fast signals
(e.g. EEG, ECG). However, there are several transducers for recording nasal and oral
flow, respiratory movements, snoring, oxygen saturation, heart rate and body position.
There is a number of possible detection modalities to distinguish respiratory airflow:
differential pressure measurements, hot wire anemometry, passive temperature sensing,
humidity sensing and CO2 measurements (Johansson 2004). The gold-standard device
for measuring respiratory airflow is the pneumotachograph (AASM 1999, Farre 2004).
Although pneumotachographs are used in sleep laboratories, they are not suitable for
routine use with PM devices at home when patients are breathing freely without masks.
A novel method for detecting respiratory airflow is to use a polyvinylidene fluoride
(PVDF) thermal sensor on the skin above the upper lip and below the nose (Berry 2005,
Nakano 2007).
Detecting respiratory (and other) movements wirelessly (e.g., using static charge
sensitive bed) is a tempting method, because the patient can sleep naturally without any
immediate contact to a sensor (Alihanka 1981, Erkinjuntti 1984). Unfortunately, this
type of sensor detects only movements and does not measure the airflow or oxygen
saturation and thus, additional contact type transducers (e.g. pressure sensors using
nasal cannulas and pulse oxymeters) are needed.
A single transcutaneous carbon dioxide sensor can accurately assess both ventilation
and oxygen saturation (Senn 2005). However, these sensors need regular re-
membraning and calibration (Eberhard 2007) and while they are applicable for use in
sleep laboratories they are not convenient for portable monitoring at home. End-tidal
CO2 measures the concentration of carbon dioxide of exhaled gas that is presumed to
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originate in the alveoli (Weese-Mayer 2000). During spontaneous breathing, the
capnogram is often distorted due to aspiration of expired gas. Furthermore, mouth
breathing is a major problem if only the nasal CO2 is measured. Recently, a flow-
through capnometer has been introduced for recording capnograms with minimum
distortion and this device can detect apnea reliably during sleep (Yamamori 2008).
Future testing and practical use will show the value of this method in the
polysomnography.
The AASM manual (AASM 2007) specifies both the desirable and minimal
sampling rates for polysomnographic recordings and the preferred sensors and
transducers. The recommendations (excluding those for EEG, ECG, EMG and ECG
signals) are presented in Table 2.8. AASM rates an esophageal pressure sensor as an
important transducer for respiratory effort detection. In a sleep laboratory it is useful,
but in PM conducted at home it is not applicable, especially if the patient has to attempt
to fix the transducers without professional help. Table 2.8 can be used as a good starting
point for the development of a type 3 PM device. In the next sections potential and
useable transducers are elaborated more precisely.
Table 2.8: The specifications for sampling rates of signals applicable to PM recording, adapted
from AASM (2007).
Signal Desirable
sampling
rate (Hz)
Minimal
sampling
rate (Hz)
Remarks
Airflow
- For apnea detection
100 25 Oronasal thermal sensor is the primary transducer
Nasal pressure
- For hypopnea detection
100 25 Nasal pressure sensor is the primary transducer
Oxygen saturation
- For detection of blood
oxygen saturation
25 10 Maximum acceptable signal averaging time is 3
seconds.
Esophageal pressure
- For respiratory effort
detection
100 25 Equal importance with inductance
plethysmography
Body position 1 1
Snoring sounds 500 200
Rib cage and abdominal
movements
- For respiratory effort
detection
100 25 Detected by inductance plethysmograpy
(Equal importance of esophageal pressure)
- Minimal digital resolution is 12 bits per sample.
- Respiration signal bandwidth is from 0.1 Hz to 15 Hz.
- Snoring signal bandwidth is from 10 Hz to 100 Hz.
For nasal pressure transducers which identify snoring occurring on top of the airflow waveform.
 To enable adequate artifact rejection.
 For snoring sounds, a 500 Hz sampling rate is recommended for better detection of the amplitude
variation. A much lower sampling rate is acceptable, if loudness or intensity level presentation can be
produced by pre-processing of snoring sound.
 For recording of ribcage and abdominal movements using inductance plethysmography, a 100 Hz
sampling rate allows a more accurate detection of cardiogenic oscillations and a more efficient
assessment of artefacts.
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Recording of oronasal airflow with a thermistor
Thermistor is a special type of resistor whose resistance varies with temperature (U.S.
Patent No: 2,021,491). Thermistors are nonlinear sensors and they usually consist of
sintered mixtures of oxides (NiO, Mn2O3, or Co2O3) (Millman 1979).
For accurate temperature measurements, the resistance-temperature curve can be
described with the Steinhart-Hart equation
  3)ln()ln(1 RcRba
T
	 , (1)
where a, b and c are called the Steinhart-Hart parameters. T is the absolute temperature
in degrees Kelvin and R is the resistance in ohms (Steinhart 1968). The negative
temperature coefficient (NTC) thermistors can also be characterized with the B
parameter equation
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which is essentially the Steinhart-Hart equation with c = 0. R0 is the resistance at
temperature T0. Solving for R yields
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Assuming that the base temperature T0 >> T and that the thermistor resistance at T0 is A,
the previous equation can be rewritten as
)(
T
B
AeR 	 . (4)
Arranging this equation into a logarithmic form gives
T
BAR 1)ln()ln( 	 . (5)
Thus, ln(R) depends linearly on 1/T.
The thermal time constant for a thermistor is the time required for the thermistor to
change its body temperature by 63.2% of a specific temperature span when the
measurements are conducted under zero-power conditions in thermally stable
environments. The thermal time constant affects considerably the recorded signals
(Farre 2004). Large time constant values dampen fast changes and should be avoided.
When selecting a thermistor, initial resistance, size, surface material, cost and usability
must be taken into account. It should be noted that transducer self-heating will increase
the temperature of a transducer above the ambient temperature causing a positive bias to
the real temperature value. In order to remove the bias from the signal, a high-pass
filtering must be applied before the AD conversion.
A thermistor (or thermoelement) records respiratory airflow indirectly by sensing
the temperature changes during inspiration and expiration. Unfortunately, temperature
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changes are not linearly correlated to volume flow changes (Farre 2004). The amplitude
of the signal produced by a thermistor sensor depends largely on the surrounding
ambient temperature in front of the mouth and nostrils. There is no signal if the ambient
temperature is the same as the temperature of the exhaled air. Fortunately, this is rarely
a problem in clinical recordings. However, a thermistor can give only a qualitative
estimate of the airflow change which can lead to uncertainty in detecting flow limitation
events (i.e. hypopneas) (Berg 1997, Farre 1998, Redline 2007). Despite this uncertainty,
the AASM manual for scoring sleep (AASM 2007) recommends the oronasal thermal
sensor as the sensor of choice for detecting the absence of airflow in the identification
of apnea events.
Recording of nasal airflow with a pressure sensor
Since the speed of airflow in the upper airways (Figure 2.3) is much lower than the
speed of sound, it can be assumed that the air flow is locally incompressible. Further,
assuming that the flow is quasi-steady and neglecting viscous effects, the Bernoulli law
can be applied (Bernoulli 1738, Newcombe 1997, Payan 2003).
Figure 2.3: Sagittal section of the upper airways in the supine position.
A volume-flow rate in the nasal cavity (Figure 2.4) at the depth of a cannula head
can be defined as
11
1 vA
dt
dV
	 , (6)
where 1A is the cross sectional area of the nasal cavity at the level of the cannula head
and 1v is the velocity of the infinitesimal volume element at the level of cannula head.
Applying Bernoulli’s equation to the situation described in Figure 2.4 gives
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2
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where p1 and p2 are the pressures, v1 and v2 are the air flow velocities, y1 and y2 are the
elevations, is the air density and g is the gravitational acceleration. Since the
elevations y1 and y2 are almost equal and the air flow velocity v2 in the ambient air is
zero, the equation reduces to
)(
2
1 2
121 vpp 
	
  . (8)
Solving for velocity v1 gives
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Substituting this to Equation (6), gives for the volume flow rate
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Figure 2.4: The principle of the nasal flow recording with a pressure transducer.
The pressure transducer measures the differential pressure p2 – p1. According to
Equation (10) the volume flow rate is proportional to the square root of the differential
pressure. In the transducer, the measured differential pressure is converted to a voltage
signal, which is further high-pass filtered and digitized. The high-pass filtering is
needed for practical reasons, because transducer offsets are large.
Although the Bernoulli’s principle is used when recording the nasal air flow, the air
flow distribution in the nasal cavity is not necessarily uniform or laminar, the density of
air is not exactly the same in the cavity and ambient air, and the elevations are not
equal. Thus, Equation (10) is not precise. Furthermore, area A1 is not constant from
patient to patient and the cannula opening may be far from the centre of the cavity. For
this reason, a calibration factor has been suggested to be added on the right side of
equation (10). It has been noted that this calibration factor shows a considerable intra-
subject and inter-night variation because it depends on the exact position of the prongs
in the nostrils and, thus, the device cannot quantitatively estimate the flow throughout
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the night (Farre 2004). In some patients, nasal prongs with an inadequate size can
induce an increase in airway resistance (Lorino 2000). For these reasons, the measured
flow rate values cannot be absolutely correct and due to these uncertainties,
mathematical and physical models for detecting inspiratory flow limitation during sleep
have been developed (Mansour 2002, Mansour 2004).
Obviously, if only the nasal airflow is recorded and oral breathing is neglected,
apnea and hypopnea events cannot be reliably detected. Estimation of oral breathing
based on the nasal airflow signal is very difficult because of individual differences in
the geometry of the upper airways. Logically, any airflow through the mouth lowers the
pressure amplitude recorded from the nostrils. The importance of detecting absence of
airflow through both nose and mouth is stressed in the AASM recommendation (AASM
2007) which state that apnea events should be detected with a thermal sensor.
However, the AASM (AASM 2007) also recommends that hypopneas should be
detected by a nasal pressure sensor. This recommendation is based on a number of
studies showing that nasal pressure recording is an accurate method for recording nasal
airflow during sleep (Norman 1997, Ballester 1998, Series 1999, Hernandez 2001,
Thurnheer 2001, Heitman 2002, Teichtahl 2003, BaHammam 2004). In particular, the
pressure method is more sensitive than the use of a thermistor in detecting hypopneas. A
square-root linearization of pressure signal recorded with nasal prongs has been shown
to increase greatly the accuracy of detecting hypopneas and flow limitation (Farre
2001). The square-root linearization of the pressure signal to obtain the flow signal is
calculated automatically in Somnologica 3.2 (Embla Co., Broomfield, CO, USA). The
calculation algorithm is proprietary information of the manufacturer.
Recording of abdominal and thoracic respiratory efforts with
strain gauges
Body surface movements can be used to study breathing (Gribbin 1983). The
instruments which measure ribcage and abdominal motion can be divided into three
classes: i.e. those which measure circumference, linear displacement or cross-sectional
area of chest or ribcage (Gribbin 1983). A simple mechanical model of chest-wall
movement has been developed to describe combined ribcage and abdominal movements
(Konno 1967). The model has two large cylinders separated by a floppy membrane.
Both cylinders have their own pistons, which can move independently. The model can
explain movements during normal breathing (thorax and abdomen signals are in phase)
as well as during upper airway obstruction during apnea (signals are in opposite phase).
Elastic belts have been applied to record volume changes in human limbs (Whitney
1953). The same technology has been used to record circumference of thorax and
abdomen as a way to detect respiratory effort. In the early applications, the belts were
rubber tubes filled with mercury. Later, the tubes were replaced with elastic belts
containing a small elastic transducer. Most commonly, the transducer was a strain gauge
or a piezo-electric sensor (Pennock 1990). Although the use of strain gauges may cause
overestimation of central apneas (Boudewyns 1997) they are widely used in the
diagnosis of sleep apnea. Strain gauges are sensitive to body movement artefacts and
the recorded signal must be filtered to avoid emphasizing of high frequencies. Still these
sensors are applicable to measurements of respiratory movements. Electrical impedance
plethysmography has been used for recording of breathing movements (Yasuda 2005).
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In this technique, the sensor bands are attached directly to the skin. The initial raw
signal needs sophisticated signal processing to provide useful method to detect
respiratory efforts during sleep recordings (Yasuda 2005). With this method, the
cardiac-induced variations in the impedance waveform can be misinterpreted as
breathing (Brouillette 1987).
In addition, inductance plethysmography can be used for the measurement of
breathing movements (Whyte 1991, Kaplan 2000). Inductance plethysmography is
based on the use of an elastic belt containing a zigzagged wire. An alternating current is
fed through the wire. This induces a magnetic field proportional to the alternating
current. The variation in patient diameter (cross-sectional area) and composition due to
breathing causes variation in the inductance, and this variation can be measured. The
measurement principle does not rely on belt tension and the signal is linearly related
with volume changes. Unfortunately, calibration gains depend on the position of the
bands around the thorax and abdomen causing potential practical problems when the
patient changes body position during the night (Farre 2004).
From a portable-monitoring point of view, the sensors for detection of respiratory
movements should be: easy to set up, useable in different body positions, capable of
maintaining good fixation during the night, durable for long term use and easy to
connect to the ambulatory device.
Figure 2.5: Thorax and abdominal geometry and the transducers set up at the end of
exhalation and at the end of inhalation. Both transducers bend due to underlying tissue
movement and generate a signal which describes respiratory efforts.
Although the breathing movements are complicated (Figure 2.5), a simple
cylindrical physical model may be used to obtain a rough estimate of the lung volume
change (Konno 1967). Suppose that we have a cylinder (residual air left in the lungs),
which has a radius R1 and a height h. Then the volume V of the cylinder is R12h. When
the cylinder is full (at the end of inhalation), the volume is R22h. By calculating the
change of the volume, we obtain

 V = h(R22 - R12) . (11)
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Realizing that (R22 - R12) = (R2 – R1)(R2 + R1) and that the change in radius is very small
(R1  R2), Equation (11) can be rewritten as follows:
 V = 2(R2 - R1)R2h . (12)
By replacing the term R2h with a constant H and noting that the 2(R2 - R1) is the
change of circumference C, Equation (11) can be further simplified as follows:
 V = HC . (13)
Thus, the change in V is linearly related to the change in the circumference C or a
segment of it. The change in the circumference of the thorax and abdomen segments can
be very different, and in the recording of respiratory movements during sleep, these
segments must be measured separately.
Recording of peripheral blood oxygen saturation with a pulse
oxymeter
The principle of pulse oxymetry is based on different red and infrared light absorption
of oxygenated and deoxygenated hemoglobin (Figure 2.6) (Yoshiya 1980). Oxygenated
hemoglobin absorbs more infrared than red light and deoxygenated hemoglobin absorbs
more red than infrared light. Light absorption in blood can be measured with
transmission or reflectance techniques. The transmission technique, which is the most
common method, requires a reasonably translucent site with good blood flow. Typical
adult and pediatric sites are the finger, toe or ear lobe. The foot or palm of hand may be
used with infants.
Figure 2.6: Typical transducer setup of a pulse oxymeter and the light absorption spectra of
oxy- and deoxy hemoglobin (R = red, IR = infrared).
A typical oxymeter measures the red-infrared light intensity ratio, compares it to
values of an internal look-up table and then provides the SpO2 value. Most
manufacturers have their own empirical device and transducer specific look-up tables.
Kuopio University Publications C. Natural and Environmental Sciences 261: 1 - 79 (2009)
- 31 -
2 Sleep Apnea
Modern pulse oxymeters can detect variation in the light absorption due to arterial
pulsation (Figure 2.7). This information can be used to calculate heart rate. The heart
rate value is usually averaged and does not represent an exact beat-to-beat rate.
Although pulse oxymeters are widely used, they have certain limitations that must
be recognized. The fixing of the transducer emitter and detector head can be erroneous.
For example, the fingernail may have coloured polish or plastic coating, the bilirubin
level of the patient can be high, the finger can have low perfusion or the patient may
suffer from the sickle cell anemia. Furthermore, patient movements can distort pulse
oxymetry. All these factors can make the measurement either unreliable or even
impossible. However, according to the AASM manual (AASM 2007), the sensor of
choice for detection of blood oxygen saturation is the pulse oxymeter with a maximum
acceptable signal averaging time of three seconds.
Physical requirements for a pulse oxymeter for portable home monitoring are ease
of use, small size, low power consumption and good technical reliability. In addition,
the device should have a numerical display to confirm the correct fixing of the
transducer at the start of the recording.
Figure 2.7: Schematic of light absorption in a pulse oxymetry sensor. Variable absorption of
arterial blood causes variation in transmitted radiation which can be measured. Inspired by
Yoshiya (1980) and Ferrera (2006).
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Body position recording
It has been reported that collapsibility of the upper airways is strongly influenced by
body position (Penzel 2001) and in a number of patients the sleep-related breathing
problems occur in one body position only (Penzel 2006). Recording of body position is
important, since certain patients can be treated by avoiding provocative (usually supine)
positions (Cartwright 1991, Oksenberg 2000). Modern electronic acceleration sensors
often used for detection of leg movements (Itoh 2007) can be used to detect body
position as well. If one wishes to record all three dimensions, then three acceleration
sensors will be needed. However, one dimension can be omitted if only supine, prone,
left side and right side positions are recorded. Furthermore, dynamic body movements
can be recorded with accelerometers. However, if only the body position is of interest,
simple gravitation sensitive switches can be used as position sensors.
Recording of snoring sounds
Snoring is basically barometric pressure changes occurring at the same audio
frequencies as normal speech. Thus, the annoying sound of snoring can be recorded
with the same instruments (microphones and recorders) as human speech. Snoring
originates from relaxed soft tissues in the upper airways during sleep. In order to record
snoring, the recorder must be able to record signals up to 100 Hz and, thus, the digital
sampling rate must be at least 200 Hz (AASM 2007) but for more accurate detection of
amplitude variation, a 500 Hz sampling rate is desirable. For portable monitoring this
sampling rate is far too high, providing much unnecessary data. To minimize the
amount of recorded data without decreasing the diagnostic value of the signal, the
averaged amplitude level of the original audio signal can be full-wave rectified and
filtered to produce an integrated signal. This integrated signal (intensity level) can then
be sampled only a few times per second depending on the applied filters (AASM 2007).
The range of the snoring sound amplitude is so wide that its proper recording would
require 16 or more bits. However, digitising and recording so many bits in portable
monitors is not feasible. Fortunately, there are convenient integrated circuits, which can
make an analogue conversion of input signal to a logarithm form and then integrate the
result. With this method, the signal can be adequately presented with 12 bits or even
less. In addition to a microphone, the nasal pressure sensor may be used to record
snoring. The same signal conditioning precautions necessary for microphones are valid
for pressure sensors, amplifiers and digitisers.
2.4.3 Diagnostic recommendations
The American Academy of Sleep Medicine has collected recommendations to a manual
for the scoring of sleep and associated events (AASM 2007). The rules for detection of
apnea and hypopnea events are summarized in Table 2.9. The AASM suggests that the
sensor of choice for detection of an apnea event is an oronasal thermal sensor and for
detection of a hypopnea event, the sensor of choice is a nasal air pressure transducer. To
be counted as apnea or a hypopnea event, the duration of the event must be at least ten
seconds. For an apnea event, air flow amplitude recorded with an oronasal thermistor
must decrease  90% for at least ten seconds. In contrast to detection of an apnea event,
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several different criteria may be used to detect a hypopnea event. For example, the limit
for the drop in nasal pressure signal amplitude varies between 30 and 50%.
Table 2.9: Diagnostic criteria of apnea and hypopnea events (AASM 2007).
Event type Duration Sensor Amplitude
change
Criterion
fulfilled
SpO2-
drop
Arousal

Respiratory
effort
Apnea  10 s Oronasal
thermistor
Drop 90% > 90% - -
Obstructive Entire period
Mixed At the end
Central Absent
Hypopnea  10 s Nasal pressure Drop 30% > 90% 4% - -
or  10 s Nasal pressure Drop 50% > 90%  3% - -
or  10 s Nasal pressure Drop 50% > 90% - Yes -
 Fraction of the event duration that must fulfil the amplitude criterion
 Pulse oxymetry with a maximum acceptable signal averaging time of 3 seconds
 EEG must be recorded to detect arousal
 The method of choice is esophageal manometry or inductive plethysmography
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CHAPTER III
Measurement of altered consciousness
3.1 Conditions causing altered consciousness
Many medical conditions can evoke lowering of consciousness or even coma. Among
the most common causes are supra- or subtentorial lesions (haemorrhage, infarction,
tumours, head injury, cerebellar infarct or tumour, pontine haemorrhage or brainstem
infarct) which account for one third of cases. Two thirds of cases are of a diffuse and/or
metabolic origin (encephalitis, anoxia, ischemia, hypoglycemia, hepatic
encephalopathy, endocrine disorders, drug poisons or ionic and acid-base disorders)
(Posner 2007). In operating theatres patients are sedated intentionally by
anaesthesiologists with sedative agents.
It is essential that one can monitor the level of consciousness or depth of sedation in
modern intensive care units and emergency rooms (Jordan 1999). The general physical
examination is not always enough and other methods are needed. Recording of
spontaneous EEG can provide additional information for several reasons: EEG is tightly
linked to cerebral metabolism, it is sensitive to the most common causes of cerebral
injury, it can detect neuronal dysfunction and neuronal recovery, and it is the best
method for detecting epileptic activity (Jordan 1999). In addition to spontaneous EEG
recording, event-related potentials can provide valuable information on the level of
consciousness and the cortical functions.
3.2 Monitoring of the level of consciousness
The evaluation of a patient with an altered level of consciousness consists of
information on patient history, physical examination and laboratory evaluation. The
physician must begin the examination and treatment simultaneously. When the usual
laboratory tests have been evaluated and the situation has become stabilised, more
sophisticated methods can be applied. EEG recording is not yet a common method, but
it can provide valuable additional information (Jordan 1999). Techniques that use
analysis of spontaneous EEG, such as bispectral monitoring and entropy analysis, have
been used for detection level of consciousness during anaesthesia (Glass 1997, LeBlanc
2006, Hata 2009, von Delius 2009). These methods use only a few frontal EEG
channels and evaluate mathematical and statistical relationships among various
components of the EEG signal. The mathematical algorithms are an integral part of the
analysis programs of anaesthesia monitors and are proprietary information of the
company that developed them.
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However, conventional EEG measures mainly the resting or background state of the
brain. By adding exogenous stimulation (somatosensory, auditory or visual) and
recording evoked potentials, one can obtain information on the reactivity of the brain. In
particular, long-latency auditory evoked-potential measurements can be used to test the
functioning of auditory cortical areas even during situation of reduced consciousness
(Yppärilä 2002a, Yppärilä 2002b, Haenggi 2004, Yppärilä 2004a, Yppärilä 2004b).
3.2.1 General clinical examination
The initial examination of a comatose patient must be brief but thorough (Table 3.1).
This examination contains airway, breathing and circulation tests, checking of pupillary,
oculomotor and motor responses, and major laboratory diagnostic tests (Posner 2007).
Laboratory diagnostics may contain blood and urine testing, computed tomography
imaging and angiography, magnetic resonance imaging and angiography, magnetic
resonance spectroscopy, neurosonography (Doppler sonography), lumbar puncture,
ECG, EEG and evoked potential examinations. Recording of ERPs and all other evoked
potential examinations can be seen as a continuum to conventional reaction tests, such
as testing the reaction to a loud noise. A number of different scales (e.g., Glasgow
Coma Scale) have been devised for scoring patients with coma (Posner 2007).
However, no scale is adequate for all patients and the best policy in recording the results
of the coma examination is simply to describe the findings (Posner 2007).
Table 3.1: Examination of a comatose patient according to Posner (2007).
History (from Relatives, Friends, or Attendants)
Onset of coma (abrupt, gradual)
Recent complaints (e.g. headache, depression, focal weakness, vertigo)
Recent injury
Previous medical illness (e.g. diabetes, renal failure, heart disease)
Previous psychiatric history
Access to drugs (sedatives, psychotropic drugs)
General Physical Examination
Vital signs
Evidence of trauma
Evidence of acute or chronic systemic illness
Evidence of drug ingestion (needle marks, alcohol on breath)
Nuchal rigidity (assuming that cervical trauma has been excluded)
Neurological Examination
Verbal responses
Eye opening
Optic fundi
Pupillary reactions
Spontaneous eye movements
Oculocephalic responses (assuming cervical trauma has been excluded)
Oculovestibular responses
Corneal responses
Respiratory pattern
Motor responses
Deep tendon reflexes
Skeletal muscle tone
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3.2.2 Electroencephalography
The human nervous system can be divided into two parts: the central and peripheral
nervous systems. Anatomically, the central nervous system (CNS) consists of the
cerebrum, cerebellum, brainstem and spinal cord (Heimer 1995). The cerebrum has two
hemispheres which are interconnected by the corpus callosum. Both hemispheres have
four general subdivisions: the frontal, temporal, parietal and occipital lobes. The basic
element of the nervous system is the neuron (Niedermeyer 1993). Neurons transmit
information to other neurons through synapses in a chemical form. Post synaptic
potentials (PSPs) in thousands of synchronously active pyramidal cells (e.g. group A in
layer 5 in Figure 3.1) of the cerebral cortex produce electrical potentials which are
recordable on the scalp with an amplifier through appropriate electrodes. Different
information is processed in different functional areas of the cerebral cortex, and if the
Figure 3.1: A simplified picture of the origin of EEG and its recording with scalp electrodes and
a preamplifier. The polarity of surface EEG depends on the location of the synaptic activity
within cortex. A Group A receives excitatory input from thalamus in layer 4 causing a positive
potential in Electrode A and in contrast Group B receives an excitatory input from the
contralateral cortex via corpus callosum in layer 2 causing a more negative potential in
Electrode B. An EEG-amplifier input finally summarises the difference as EEG. Figure is
inspired by Westbrook (2000).
active cortex is small and perpendicular to the scalp surface, there may be only a minor
voltage difference that is seen at the inputs of the amplifier. Cerebrospinal fluid and the
scalp are much better conductors than the skull. These three layers attenuate, filter and
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smear the potentials measurable on the scalp. The amplitude of a typical scalp EEG-
signal varies from 10 to 100 V and when measured from subdural electrodes it varies
from 10 to 20 mV (Aurlien 2004). The main frequency content of the scalp EEG-signal
lies between 0.16 and 70 Hz (Nuwer 1998). A typical example of spontaneous EEG is
seen in Figure 3.2. Conventionally, EEG frequency bands have been defined as
described in Table 3.2.
Figure 3.2: Example of 8 seconds of spontaneous EEG recorded from a healthy subject with
eyes closed while awake. Electrodes Fz, Cz, Pz, and Oz were placed according to the
international 10-20 system referred to the right mastoid.
Table 3.2: The definitions of frequency bands of EEG (Niedermeyer 1993, Rampil 1998).
Band Frequency range (Hz)
Delta < 4
Theta 4 – 7
Alpha 8 – 12
Beta 1 13 – 20
Beta 2  21
Gamma 35 - 45
Clinical electroencephalography devices should comply with the general standards
for recording of the digital electroencephalogram (Nuwer 1998). However, these
standards should not restrict research use of EEG, or its use outside EEG laboratories
and thus exceptions can be accepted. For example, the standard suggests that at least 24
and preferably 32 EEG channels should be used, but normal bispectral (BIS) or entropy
monitors use only two or a maximum of four frontal channels. However, most of the
recommended values are universally valid. The minimum digital sampling rate is 200
Hz and the corresponding anti-aliasing filter prior to digital sampling is 70 Hz (roll-off
rate at least 12 dB/octave). Digitization must use a resolution of at least 12 bits and must
be able to resolve the EEG-signal down to 0.5 V. Preamplifier input impedances
should be more than 100 M and interchannel cross-talk less than 1% of signal
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amplitude. The common mode rejection ratio (CMRR) should be at least 110 dB and
noise should be less than 0.5 VRMS (RMS is root mean square). In the recording, the
contact impedances should be less than 5 k.
Basically EEG artefacts are voltage changes that do not originate from the patient’s
brain. External technical artefacts can arise from other electrical equipment and a
qualified EEG technician must be able to recognise when the EEG is distorted due to
technical reasons. Physiological artefacts (eye movements, muscular activity etc.) are
generated from the patient him/herself and they can be sometimes used as signs of
consciousness level. In intensive care units, artefacts due to other equipments are
generally more serious than those encountered in laboratories designed for clinical EEG
and ERP recordings (Jordan 1999, Young 1999).
EEG is irreplaceable in diagnosing epilepsy or determining the level of sedation
when a status epilepticus patient is being given with general anaesthesia. Recording of
EEG has an important role in investigation of encephalitis, Creutzfeld-Jakob disease or
paroxysmal events with unknown etiology and when diagnosing brain death. While the
unconscious patient may be investigated with other methods, EEG can provide
additional diagnostic information and help in estimating the prognosis.
3.2.3 Auditory evoked potentials
Sensory stimuli produce time-locked electrical activity that can be recorded on the
scalp. These evoked potentials can be classified according to the applied stimulus into
three main categories: somatosensory (SEP), visual (VEP) or auditory (AEP) evoked
potentials. Evoked potential recordings can be used to localise lesions, or monitor a
sensory pathway during surgical procedures. The functioning of the auditory pathway
(Figure 3.3) can be measured with evoked potentials which are usually divided into
three subcategories according to their latencies. Short-latency potentials (below 10 ms)
originate from the brainstem and the recording of these potentials is called brainstem
auditory evoked potential (BAEP) recording. When the latencies are between 10 ms and
50 ms, the test is called middle-latency evoked potential (MLAEP) recording. The first
negative peak (around 20 ms) of MLAEP may be of thalamic origin and the later peaks
probably represent cortical phenomena (Pockett 1999). Both BAEP and MLAEP use
broadband clicks as stimuli at a rate of about 10 Hz. Longer latency evoked potentials
(LLAEP) (over 50 ms) form their own category and they are commonly named as
event-related potentials (ERPs) (Goodin 1994). The stimulation for ERPs is usually
done with beep-like sounds (i.e. sine-wave tones).
Comparison of Figures 3.2 and 3.4 show that the baseline EEG amplitude is much
larger than the ERP responses. Thus, signal averaging is needed in order to obtain clean
representative ERP curves. This is accomplished by summing at least several tens of
original single responses and dividing the sum by the number of responses. This
averaging operation can be done in real time or by means of an offline analysis after the
recording. Offline analysis has the advantage that artefacts can be rejected
mathematically or by visual selection. The basic assumptions of signal averaging are
that the response to a sensory stimulus does not change during stimulation (i.e. it is
deterministic) and that the background EEG activity is stochastic (a zero-mean process
with variance that does not change during the recording). These assumptions are not
always valid, since habituation may affect the responses during the recording (Ritter
1968).
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Figure 3.3: Simplified schematic presentation of the auditory pathway, adapted from Felten
(2003) and Martin (2003). Transversal sections of medulla oblongata and midbrain and a
coronal section of the cerebrum are shown along the route of the auditory pathway.
The ERPs measure the functional state of the cortex. They have exogenous
components determined mainly by the physical properties of the stimuli (frequency,
intensity and duration) and endogenous components determined by the task
requirements and instructions, the psychological relevance of the stimulus and the
subjects’ psychological state (Donchin 1978). Three main components can be seen in
auditory ERP measurements: a negative peak around 100 ms (N100) (Figure 3.4), a
mismatch negativity (MMN) response around 100 - 200 ms (Figure 3.5), and a positive
peak around 300 ms (P300) (Sutton 1965), (Figure 6a in Study IV). N100 and MMN
responses are of exogenous origin and P300 is of endogenous origin (Donchin 1983).
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The N100 response is best seen in the central region (i.e. near the Cz electrode when
referred to M1 or M2). It reflects mainly the activation of the auditory cortices in the
temporal lobe and it is a sum of several functionally distinct and temporally overlapping
subcomponents (Vaughan 1970, Wolpaw 1975, Hari 1982, Näätänen 1987). The MMN
response appears only after an infrequent stimulus that differs from the ongoing sound
stream of frequent stimuli. It is considered to indicate the presence of a memory system
that stores the physical characteristics of the frequent stimulus (Näätänen 1978,
Näätänen 1992). It has been suggested that frontal brain areas play an important role in
the generation of MMN (Giard 1990, Alho 1994, Picton 2000). When the subject
attends to infrequent target tones, the P300 response is generated. It is suggested to
reflect higher brain functions related to cognitive stimulus evaluation, memory and
attention. The P300 wave has its maximum at the parieto-occipital electrodes (Polich
1999). A smaller P300 fronto-central response is also generated by an unattended
situation (Squires 1975, Plourde 1993).
Figure 3.4: Passive oddball ERP responses to standard tones from a subject who was a free
diver and who volunteered to undergo a hypoxia exercise. The recording (authorized by the
local ethics committee) was done with the device developed in Study IV. During hypoksia N100
component is delayed.
It has been shown that deepening of the level of sedation increases the latency but
decreases amplitude of the N100 (Yppärilä 2002a). Thus, these measures may be used
as measures of the depth of sedation. In a recent study (Westeren-Punnonen 2005), the
auditory ERPs were found to recover faster than the EEG after ventricular fibrillation.
This suggests that ERPs could have potential advantage over EEG in the prognosis of
the recovery of brain functions after trauma or surgery.
In addition to monitoring the level of consciousness, ERPs have shown promice in
investigations of disorders in which consciousness is impaired. For example, prolonged
latencies of P300 have been found in Alzheimer’s disease (Polich 1990). The
lengthening of the P300 latency is also found in healthy individuals who are at an
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increased risk of acquiring Alzheimer’s disease, suggesting the possibility for early
screening for this disease (Saito 2001). A decrease in the amplitude of the P300 has
been found in Parkinson’s disease (O'Donnell 1987), schizophrenia (O'Donnell 1999)
and depression (Gordon 1986). Furthermore, it has been shown that easily distractible
adolescents have enhanced frontal and reduced parietal P300 amplitude compared to
non-distractible adolescents (Määttä 2005).
Figure 3.5: Passive oddball ERP responses to deviant tones from a subject who was a free
diver and who volunteered to undergo a hypoxia exercise. During hypoksia MMN response
clearly delays.
Technical requirements for ERP recording devices are similar to those of EEG
(Nuwer 1998) and evoked potential (Nuwer 1994) devices. In addition, the stimulator of
an ERP recording device must be able to produce different auditory stimulus sequences
at a volume level adjusted according to the hearing level of the patient. The time stamps
of stimulus events should be precisely handled with respect to incoming EEG in order
to provide accurate averaging. For most ERP purposes, an A/D converter using 12 bits
(4096 values) is sufficient, provided that the incoming signal is amplified properly
(about 10000 times) to range over at least 8 bits (Picton 2000). The artefacts to be
avoided in ERP recordings are virtually the same as those described in Chapter 3.2.2 for
EEG recordings.
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CHAPTER IV
Objectives of the thesis
Sleep apnea syndrome is a highly underdiagnosed disease with potentially serious
consequences on both the health of the individual and on national health care budgets.
The underdiagnosis is partly attributable to the lack of affordable and reliable devices
suitable for telemedical diagnostics of the disease. The event-related potentials have
shown good promise for diagnosis of depth of sedation and level of consciousness.
However, there is scarcity of portable devices that would enable the measurement of
event-related potentials in intensive care units. The main aim of this thesis was to
respond to this demand for appropriate diagnostic devices. The specific objectives were:
1. To design, construct and evaluate a compact, technically reliable and easy-to-use
eight-channel (Type 3) device (Venla) suitable for diagnostics of sleep apnea.
2. To investigate the diagnostic and technical reliability of a portable seven-channel
(Type 3) recording device (APV2) suitable for clinical use in hospital and at
home.
3. To investigate the suitability of analysis software primarily designed for one
specific make of portable monitoring device for use with other devices and to
evaluate the reliability of automatic analysis in detection of mixed and central
apneas.
4. To design, construct and evaluate a compact, portable and automatic five-channel
auditory ERP recording device (Emma) suitable for clinical use in intensive care
units and emergency rooms.
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CHAPTER V
Methodology
This thesis consists of four independent studies (I – IV). In this section, the materials
and methods used in the studies are summarized. A summary of the study design is
presented in Table 5.1.
Table 5.1: Materials and methods used in Studies I – IV.
Study Instrument Patients Place of recording
I Venla, Embla 11 males,
8 females
Sleep laboratory
I Venla / Embletta 77 males, 29 females / 116
males, 53 females
Home
II APV2, Embla 5 males, 5 females Sleep laboratory
II APV2 / Embletta 149 / 169 Home
III Venla / Embletta 71 males, 29 females / 114
males, 53 females
Home
IV Emma 4 males EEG-laboratory
 Simultaneous recordings.
 Recorded signals: Air flow (nasal pressure sensor, oronasal thermistor), breathing movements (thorax
and abdomen strain gauge), oxygen saturation (pulse oxymeter), heart rate (pulse oxymeter), snoring
(microphone) and body position (gravitation sensitive switches).
 Recorded signals: Air flow (nasal pressure sensor, oronasal thermistor), breathing movements (thorax
and abdomen inductive belts), oxygen saturation (pulse oxymeter), heart rate (pulse oxymeter),
snoring (nasal pressure sensor and snoring sensor), body position (accelerometer), audio and video.
Recorded signals: Air flow (nasal pressure sensor, oronasal thermistor), breathing movements (thorax
and abdomen piezo belts), oxygen saturation (pulse oxymeter), heart rate (pulse oxymeter), snoring
(nasal pressure sensor and snoring sensor), body position (internal accelerometer).
 Recorded signals: Air flow (nasal pressure sensor), breathing movements (internal accelerometer and
abdominal strain gauge), oxygen saturation (pulse oxymeter), heart rate (pulse oxymeter), snoring
(nasal pressure sensor) and body position (internal accelerometer).
 Recorded signals: EEG, ECG and SEP.
5.1 Patients and methods
The clinical evaluation of Venla (Study I) was carried out in the Department of Clinical
Neurophysiology in Kuopio University Hospital in two phases. The subjects were
clinical patients with suspected sleep disorders, especially OSAS and they were judged
to require a sleep study. All measurements were part of a normal clinical investigation.
The first part of the clinical evaluation was arranged by recording 19 patients (11 males
and 8 females) simultaneously with Venla and with a clinical reference instrument
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(Embla, Embla Co., Broomfield, CO, USA) in a sleep laboratory. Permission for the
experiment was obtained from the ethical committee of Kuopio University Hospital.
The patients were given oral and written information about the trial protocol, and they
provided written consent. The second part of the clinical evaluation included a total of
323 ambulatory home recordings and 275 of those were diagnostically acceptable while
48 recordings failed and were excluded due to missing signals. The numbers of
successful recording with Venla and with the commercial ambulatory device (Embletta,
Embla Co., Broomfield, CO, USA) were 106 (77 males and 29 females) and 169 (116
males and 53 females), respectively.
The first part of Study II was carried out in the Department of Clinical
Neurophysiology with the same indications and ethical justifications as in Study I. Ten
ambulatory recordings (5 males and 5 females) were carried out simultaneously with the
APV2 device and the reference instrument Embla, in the sleep laboratory. In the second
part of Study II, the technical reliability of APV2 was evaluated on the basis of 149
consecutive home recordings. As a reference, a total of 169 patients having suspected
OSA were studied with a commercial ambulatory device (Embletta).
In Study III, the recordings made in Study I were re-analysed. However, a small
number (N = 8) of recordings were omitted from Study III since the signal quality was
not good enough for automatic analysis. The start and stop times for the automatic
analysis were set manually by the researcher reviewing the traces with the help of the
patient’s sleep log and after visual inspection of the data. The default analysis
parameters are listed in Tables 5.3 and 5.4. After the automatic analysis, a manual
analysis was performed and the results of the analyses were compared.
In Study IV, a preliminary clinical evaluation of the Emma device was done by
recording auditory ERPs in four male volunteers. Two of them also participated in SEP
measurements and one in the recording of ECG and spontaneous EEG.
5.2 Technical description of evaluated devices
In Studies I – III, four different devices (Venla, APV2, Embletta and Embla) were used
to record sleep apnea. In the laboratory recordings the reference instrument was a
commercial polysomnography device Embla N7000 (Embla Co., Broomfield, CO,
USA), which is a Type 1 device (Table 2.6). The other three devices belong to Type 3,
and their technical properties are summarized in Table 5.2. The device developed for
evoked potential recordings in Study IV is described separately in Chapter 5.2.3.
5.2.1 Venla
The Venla device (Figure 1 in Study I) consists of a main unit containing electronics
and a connector panel for attaching the transducers. The device is powered with two
AA-size 1.5 V batteries and has a liquid crystal display (LCD) screen to display the real
clock time, oxygen saturation, heart rate, number of recordings in memory, maximum
available recording time, body position and push button press.
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RH16, Mitsubishi Materials Co., Tokyo, Japan) (Figure 5.1) is used for recording of the
oronasal airflow. According to the manufacturer’s specifications, the thermal time
constant of an individual element is 6 s and the heat dissipation constant is 0.6 mW/oC.
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Table 5.2: A summary of technical properties of the Type 3 ambulatory devices compared in
this thesis.
Feature Venla APV2 Embletta
Dimensions
(HWD in mm)
52  137  230 27  86  116 20  65  124
Weight (kg) 0.734 0.239 0.156
Power source 3V battery
(2 AA)
3V battery
(2 AA)
3V battery
(2 AA)
Display Alphanumerical LCD
(4 20 characters)
Alphanumerical LCD
(2 16 characters)
LED lights
Memory Internal RAM
(2.5 MB)
Internal CF
(128 MB)
Internal
(16 MB)
Number of channels 8 7 Typically 10
Airflow recording Nasal pressure sensor
+ oronasal thermistor
Nasal pressure sensor Nasal pressure sensor
+ oronasal thermistor
Respiratory effort
Thorax
Abdomen
Strain gauge
Strain gauge
Accelerometer
Strain gauge
Piezo belt
Piezo belt
Body position External tilt switches Internal accelerometer Internal accelerometer
Oxygen saturation Nonin XPOD 3011 Nonin XPOD 3011 Nonin XPOD 3012
Snoring Microphone on
the nose
Nasal pressure sensor Nasal pressure sensor
+ snoring sensor
Pulse Oxymeter Oxymeter Oxymeter
Real time sensor
checking
Alphanumerical +
coarse graphical
display
Alphanumerical +
graphical
display
LED lights
Signal sampling
frequencies
1 Hz for SpO2 and HR,
8 Hz for all others
1 Hz for SpO2 and HR,
10 Hz for all others
3 Hz for SpO2 and HR,
20 Hz for pressure and
10 Hz for all others
LED stands for light emitting diode
RAM stands for random access memory
CF stands for compact flash which is a standardised type of memory card
Figure 5.1: Printed circuit board of the oronasal thermistor and the circuit diagram of its spike-
protected connection to the equipment.
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A modified pressure sensor chamber (PTAFlite, Pro-Tech Services Inc., Mukilteo,
WA, USA) is used as the pressure transducer for recording of airflow with a nasal
pressure cannula (Embla Co., Broomfield, CO, USA). The chamber contains a sensitive
piezo element that converts small pressure changes into voltage values. The first
amplifier stage (U1) in Figure 5.2 is direct-current (DC) coupled and it has a bias offset
trimming resistor, RV1. During recordings, the thermistor sensor and the nasal pressure
cannula are taped together to help the patient to fix the transducers in front of the mouth
and the nostrils for recording.
Figure 5.2: Nasal pressure transducer and the circuit diagram of the first amplifier stage.
For the recording of respiratory effort via movements of thorax and abdomen, a
special strain gauge transducer was developed (Figure 5.3). They consisted of a 0.5 mm
thick double-sided printed-circuit laminate plate (15 mm in width and 95 mm in length)
and two small strain-gauge elements (KFG-5-350-C1-11, Kyowa Electronic Instruments
Co. Ltd., Tokyo, Japan) glued to both sides of the laminate (Figure 5.4). The thorax
transducer is taped onto the patient’s skin between the left mamilla and the left collar
bone. The abdominal transducer is taped above the lowest rib on the right side.
Figure 5.3: Printed circuit board of a strain gauge transducer and a sensing element.
Blood oxygen saturation and averaged heart rate were measured with a commercial
pulse oxymeter (Nonin XPOD 3011, Nonin Medical Inc., Plymouth, MN, USA)
connected via a serial port to the processor of the device. The serial port uses a baud rate
of 9600 and an eight-bit data length. The saturation and heart rate values are updated
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once per second and displayed on the LCD screen, which enables monitoring of the
signal quality at the start of the recording. The oxymeter provides the saturation and
heart rate values as integer numbers and thus the resolution is 1% and 1 beat per minute,
respectively.
Figure 5.4: Cross section of a strain gauge transducer (on the left) and the circuit diagram of its
electronic connection (on the right). The resistive elements, R30 and R31, are connected in
series with the protective biasing resistors, R32 and R33. The direct-current (DC) coupled
output from between the elements is connected via a protective resistor, R34, to the first
amplifier stage. Resistor R35 connected to virtual ground (VGND1) is for zero biasing when the
transducer is not connected.
Figure 5.5: Cross section of a body position sensor in supine position (switches A and B are
closed). When the patient is lying on the right side, the ball inside B goes to the outer end and
the switch opens, but switch A remains closed. When the patient is lying on the left side, the
states of the switches A and B are reversed. When the patient is in the prone position, both
switches are open.
A hemisphere-shaped (39 mm in diameter) body position sensor (Figure 5.5) has
two internal gravitation sensitive mechanical tilt switches (CW 1300-1, Conus
International, Clifton, NJ, USA). The switches are fixed at a perpendicular angle to each
other and at a 45-degree angle to the skin plane (plane X in Figure 5.5). With this
arrangement, all main sleeping positions – supine, prone, left, and right – can be
detected. Upright and upside down positions cannot be detected with this sensor.
Usually the patient is in the upright position only when he/she is awake and this
situation is apparent from other signals (e.g. from respiration effort signals). The
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common contacts of the switches A and B are connected to each other and to the system
ground. The remaining contacts of A and B are biased through 100 kresistors to the
operating voltage of the processor and connected to different digital inputs of the
processor producing two-bit binary information on the body position. One extra bit is
added by driving a digital line through the sensor connectors to detect the presence of
the transducer. Thus, three bits are used to present position information in the data
memory. During the recording, the sensor is taped onto the skin overlying the sternum.
A biased electret microphone is taped onto the patient’s nose to record snoring
sound. In order to improve visual inspection of weak snoring sound signals and to
prevent signal clipping with high volume snoring, the microphone signals are processed
with a special analogue circuit U4 (SSM2165, Analog Devices Inc., Norwood, MA,
USA) (Figure 5.6). This circuit effectively produces an analogue voltage that represents
a logarithmic value of the input-signal. The logarithmic signal is further amplified and
low pass filtered before the analogue-to-digital (AD) conversion. With this arrangement,
the final recorded signal represents voice pressure levels in the decibel scale and the
sampling frequency can be relatively low, e.g. 8 Hz.
Figure 5.6: Circuit diagram of the biasing, signal amplification and logarithmic conversion
circuits of the electret microphone.
The Venla device is designed and constructed around an eight-bit embedded
processor, Atmega 128 (Atmel Corp., San Jose, CA, USA), driving three two-channel
12-bit analogue-to-digital (ADC) converter chips, a universal serial bus (USB), an LCD,
a random access memory (2.5 MB), a real time clock and a calendar (Figure 2, Study I).
The embedded program is written in C in CodeVisionAVR programming environment
(HP InfoTech S.R.L., Bucharest, Romania) and saved to the flash memory of the
processor. The electronic erasable programmable memory of the processor is used to
store setup parameters and start and stop times and dates of the recordings. The external
RAM stores the recorded data of all (maximally 99) separate recordings in a special
packaged form. The device has a back-up battery to guarantee the security of internal
clock, calendar and data in the RAM.
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For data transfer, conversion and analysis, three computer programs were developed
with C++ (Borland C++ 5.01 Development Suite, Borland International, Inc.,
Cupertino, CA, USA). One program is used for transferring the data from the RAM of
the device to the computer. This program also automatically synchronises the clock and
calendar of the device with the computer and enables the user to erase all the recorded
data in the RAM. Another program was developed for review and analysis of the
recorded data. The third program provides conversion to European data format (Kemp
2003) and to a format readable with the Somnologica 3.2 (Embla Co., Broomfield, CO,
USA) PSG analysis software.
Prior to any clinical recording, the device was thoroughly technically inspected with
reliable laboratory instruments in our own laboratory. In order to ensure that the
requirements of the International Special Committee for Radio Interference (CISPR 11
EN 55,011) were fulfilled (Williams 1996), the radio frequency emissions were
inspected in an electromagnetic compatibility (EMC) laboratory (Pohjois-Savo
Polytechnic, Kuopio, Finland).
5.2.2 APV2
The APV2 device (dimensions: 86 mm 116 mm  27 mm, weight 0.239 kg) evaluated
in Study II is a successor of the Venla device. It records nasal and oral air flow (when
an oronasal cannula is used), respiratory effort movements (thorax and abdomen), body
position, snore sound level, blood oxygen saturation and heart rate. The air flow is
measured with an internal pressure sensor which also detects the snore sound level as a
ripple on the measured air pressure signal. The strain gauge transducer developed in
Study I was used for the recording of abdominal respiratory movements. Thoracic
movements are recorded as a ripple signal with an internal accelerometer sensor that
primarily detects body position. An external commercial pulse oxymeter (Nonin XPOD
3011, Nonin Medical Inc., Plymouth, MN, USA) is used to record blood oxygen
saturation and averaged heart rate. The device has an LCD screen to display oxygen
saturation, heart rate, and other parameters, as well as basic operating instructions for
the patient. An internal compact flash (CF) memory card is used for storing the data.
All transducers (except the oronasal cannula) are fixed permanently to the APV2
device and the device contains no buttons. The purpose of this simple design is to
enable the operation with minimal or no training. For example, the recording is started
and stopped by inserting and removing the batteries, respectively. The recorded data is
stored in an encrypted format and no confidential patient information is included in the
file. No special program is needed to transfer the data from the CF card to a computer or
directly to the internet server. The transfer can be done with ordinary Windows tools or
by means of a web browser. On the server, the encrypted data can be converted to EDF
and Somnologica 3.2 formats for review and analysis.
5.2.3 Emma
The Emma device (dimensions: 344 mm  173 mm  308 mm, weight 8.6 kg) designed
and constructed in Study IV consists of two main blocks: a data logger and an audio
stimulator (Figure 5.7). The liquid crystal displays (LCDs), pushbuttons, opening for a
memory card and switches of both blocks are arranged on the front panel. A battery
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compartment, an electrode connection panel and a connector for headphones are placed
at the back.
Figure 5.7: The block diagram of the Emma device.
The core of the data logger is a 16-channel data logger card containing four four-
channel 22-bit sigma-delta analogue-to-digital converter (ADC) chips (AD7716, Analog
Devices Inc., Norwood, MA, USA), a digital signal processor (DSP, ADSP-2181 KS-
133, Analog Devices Inc., Norwood, MA, USA) and a couple of logic and memory
chips. The logger card is accompanied by a preamplifier card having four preamplifier
channels for EEG and one for ECG. These channels have an amplification of 20 and
10, respectively, input impedances of 10 M, and bandwidths from 0.3 Hz to 10 kHz.
The analogue inputs are protected against static charge spikes, which are common in
clinical situations, and against other forms of electromagnetic interference (e.g. radio
transmissions).
The audio stimulator block consists of a commercial DSP demo board (EZ-KIT
Lite, Analog Devices Inc., Norwood, MA, USA) and several digital logic, memory and
analogue circuit chips. This block produces the stimulation sequences constructed of
two different pre-programmed 84 ms sine-wave tones (800 or 560 Hz) (Table 1 and
Figure 4 in Study IV). Front panel thumb wheels can be used to select the desired
stimulation program and stimulation intensity.
Both blocks have their own internal (embedded) programs to manage all the
functions of the data logger (Figure 3 in Study IV), and to produce the desired audio
tones. The logger program reads the setup parameters from a PC Card hard disk (or
from a compact flash card) at the equipment start-up. For checking the data and signal
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quality, a special reviewing program was developed with C++ (Borland International,
Inc.).
Prior to clinical evaluation, the device was thoroughly technically validated in our
own laboratory. Furthermore, the radio frequency emission levels were inspected in an
electro magnetic compatibility (EMC) laboratory (Pohjois-Savo Polytechnic, Kuopio,
Finland).
5.3 Data analysis
Commercial PSG software (Somnologica 3.2) was used for the somnographic analysis.
All apnea, hypopnea, oxygen desaturation and snoring events were marked manually
after automatic pre-analysis according to the rules described in Table 2.9. In order to
detect a hypopnea event, the first rule (airflow amplitude drop 30% and SpO2 drop
4%) in Table 2.9 was used. The time markers for falling asleep and waking up were
placed based on the patient’s sleep log and on visual inspection of the raw signals. The
default parameters for automatic detection of apneas, hypopneas and oxygen
desaturation events are listed in Tables 5.3 and 5.4. The default values in both tables for
automatic detection of hypopneas indicate that the first rule for detection of hypopnea in
(Table 2.9) was applied in Somnologica. Events during a movement period, 20 s after a
movement period or in upright position or while awake were not accepted as apnea-
hypopnea or oxygen desaturation events.
Table 5.3: Limits for accepting an event as apnea or a hypopnea event in the automated
analysis in Somnologica 3.2.
Parameter Apnea Hypopnea
Maximum breath rate 1 Hz -
Minimum air flow amplitude drop 80% 30%
Minimum event duration 10 s 10 s
Maximum event duration 120 s 120 s
Shortest acceptable breath duration 0.3 s 0.3 s
Short breath amplitude 30% 75%
Preceding reference period 100 s 100 s
Accompanied by desaturation No Yes
Maximum delay from event to desaturation - 20 s
Table 5.4: Limits for accepting an event as a desaturation event in the automated analysis in
Somnologica 3.2.
Parameter SpO2
Artefact detection:
Exclude interval 10 s
Lowest saturation 50%
Allowed fluctuation 10%/s
Desaturation analysis:
Minimum slope of the fall 0.1%/s
Maximum slope of the fall 5%/s
Maximum plateau duration 20 s
Minimum desaturation duration 0 s
Maximum desaturation duration 120 s
Minimum fall of desaturation 4%
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Statistical analyses were conducted with the SPSS software (version 14.0, SPSS
Inc., Chicago, IL, USA). The significance of differences between polysomnographic
parameters recorded simultaneously in the sleep laboratory (an ambulatory device
versus the reference instrument) in Studies I and II was investigated with the Wilcoxon
signed rank-test (Field 2009). The significances of differences between the
polysomnographic parameters recorded with the ambulatory devices (Venla versus
Embletta and APV2 versus Embletta) in Studies I and II were investigated with the
Mann-Whitney U test. In Study III, the significance of differences between the
automatically and manually determined polysomnographic parameters was assessed
with the Wilcoxon signed rank-test. The correlation analyses were conducted by means
of the Pearson correlation analysis. Data analysis (filtering, sorting, and averaging) of
EEG and ERP signals in Study IV was done using Scan 4.3 (NeuroScan Inc., Sterling,
VA, USA) software package. Origin 6.0 and 7.5 program packages (Microcal Software
Inc., Northampton, MA, USA) were used to plot the signals and other curves, to
calculate noise statistics and to conduct correlation and Bland-Altman analyses (Bland
1986) Corel Draw versions 7.0 and 9.0 (Corel Corp., Ottawa, Canada) were used for the
creation of the graphical presentations.
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CHAPTER VI
Results
6.1 Evaluation of ambulatory devices for screening of sleep
apnea
Prior to the clinical applications, the ambulatory device designed and constructed in
Study I (Venla) was evaluated with extensive technical tests. The radio-frequency
emission generated by Venla was found to be below the limits set by the International
Special Committee for Radio Interference. The measured power consumption of Venla
was 0.33 W, which allows an operation time of 17.2 h with two AA batteries.
The clinical evaluation of the ambulatory devices began with simultaneous
recordings with a reference sleep laboratory instrument. Although the recorded signals
were qualitatively highly similar (Figure 6.1), more precise inspection revealed that
there were certain differences between the signals. For example, the nasal flow signal
recorded with Venla or APV2 has more noise than the signal recorded with the
reference instrument. Figure 6.2 demonstrates an airflow recording with a nasal pressure
cannula and an oronasal thermistor when signs of airflow through the mouth are seen.
The greatest differences between Venla and the other devices are seen in snore
sound signals. Importantly, Venla detected more snoring than APV2 or the reference
instrument. This is attributable to the technical differences in the recording of snoring
and indicates that the low sampling frequency (8 Hz) used in Venla is sufficient.
Furthermore, due to the lower sampling frequency (1 Hz versus 3 Hz) used in Venla and
APV2 for HR and SpO2 signals, these curves look coarser than those recorded with the
reference instrument. However, despite these differences, the apnea events could be
detected similarly with all three devices.
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Figure 6.1: Examples of polysomnographic signals recorded from a patient suffering from
severe sleep apnea with Embla (a), with Venla (b) and with APV2 (c). The recording was done
in a sleep laboratory simultaneously with all three devices. Despite some differences in signal
quality, the apnea events could be detected similarly with the devices. The second signal
(calculated nasal flow) in all panels is a square root of the first signal (pressure recorded with
nasal cannula). Heart rate (HR) is measured with a pulse oxymeter and represented in beats
per minute (BPM).
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Figure 6.2: Example of airflow recording with a nasal pressure cannula and an oronasal
thermistor with the Venla device. In the pressure channel there are four events (A – D) which
appear as apneas. However, in the thermistor channel, there are signal variations (marked with
up arrows) within the events A and B, suggesting presence of airflow. There is additional
evidence for this in the snore channel showing loud noise peaks (down arrows) simultaneously
with the signal variations seen in the thermistor channel. Oxygen desaturation signal shows that
all respiratory events (A – D) cause desaturation.
No statistically significant differences (Wilcoxon signed-rank test) were found in
the AHI and ODI values determined from simultaneous sleep laboratory measurements
with Embla, Venla and APV2 (Studies I and II in Table 6.1). The AHI values
determined with Venla and APV2 were strongly correlated with those obtained with the
reference instrument (Embla) (r2 = 0.994, p < 0.0001, AHIVenla = 1.014  AHIEmbla +
0.402 and r2 = 0.994, p < 0.0001, AHIAPV2 = 0.993  AHIEmbla + 0.505). For the oxygen
desaturation index, the correlations were equally strong (r2 = 0.995, p < 0.0001,
ODIVenla = 0.983  ODIEmbla + 0.305 and r2 = 0.992, p < 0.0001, ODIAPV2 = 0.997 
ODIEmbla + 0.226). It is important that the diagnostic sensitivities of Embletta, Venla and
APV2 were rather similar (Table 6.2).
The second part of the clinical evaluation (Study I) was arranged by conducting 275
successful ambulatory home recordings in order to compare the performance of the
devices in routine clinical use. No statistically significant differences were found in the
AHI, ODI or hypopnea values between Embletta and Venla (Table 6.1). Furthermore,
the diagnostic sensitivities of the devices were found to be similar (Table 6.2).
One important finding was that the novel devices showed better technical reliability
than the commercial reference device (Embletta). This reduces the failure costs
considerably due to a significantly lower number of re-recordings required (Table 6.3).
The most common reasons for technical failures of all devices were loss of either
airflow or oxygen saturation signals.
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Table 6.1: Comparison of the respiratory parameters (mean  SD) recorded with the evaluated
devices in Studies I and II. No statistically significant differences were detected in the AHI and
ODI values determined with the devices.
Parameter Reference Device under test
(Simultaneous recordings, Study I) Embla (N = 19) Venla (N = 19)
AHI (1/h) 18.9  25.2 19.6  25.7
ODI (1/h) 17.4  25.0 17.4  24.6
Obstructive apnea (1/h) 7.3  13.9 10.4  17.9 *
Hypopnea (1/h) 6.0  5.4 5.5  4.4
(Simultaneous recordings, Study II) Embla (N = 10) APV2 (N=10)
AHI (1/h) 26.3  26.6 
ODI (1/h) 27.1  27.3 
Obstructive apnea (1/h) 11.1  13.7 
Hypopnea (1/h) 8.8  8.0 
(Group comparison, Study I) Embletta (N = 169) Venla (N = 106)
AHI (1/h) 12.4  13.5 
ODI (1/h) 11.2  11.7 
Obstructive apnea (1/h) 5.6  6.7 
Hypopnea (1/h) 5.2  4.7 
* p < 0.05 (Wilcoxon signed rank-test)
Table 6.2: Resulting clinical severity of sleep apnea in different devices (Studies I and II).
Diagnosis Reference Device under test
(Simultaneous recordings, Study I) Embla (N = 19) Venla (N = 19)
Normal (AHI < 5, %) 36.8 36.8
Mild (5  AHI < 16, %) 42.1 42.1
Moderate (16  AHI  30, %) 0.0 0.0
Severe (30 < AHI, %) 21.1 21.1
(Simultaneous recordings, Study II) Embla (N = 10) APV2 (N=10)
Normal (AHI < 5, %) 20.0 20.0
Mild (5  AHI < 16, %) 50.0 40.0
Moderate (16  AHI  30, %) 10.0 10.0
Severe (30 < AHI, %) 20.0 30.0
(Group comparison, Study I) Embletta (N = 169) Venla (N = 106)
Normal (AHI < 5, %) 49.1 51.9
Mild (5  AHI < 16, %) 26.0 25.5
Moderate (16  AHI  30, %) 11.8 8.5
Severe (30 < AHI, %) 13.0 14.2
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Table 6.3: Summary of the technical reliability and the estimated yearly failure costs of the
evaluated ambulatory devices. The Venla and APV2 devices showed better technical reliability
and lower estimated failure costs compared to the commercial reference device.
Feature Venla APV2 Embletta
Number of patients (N) 106 149 169
Technically perfect (%) 89.1 90.0 77.2
Diagnostically acceptable (%) 93.3 96.0 80.8
Totally failed (%) 6.7 4.0 19.2
Estimated yearly failure costs () * 2948.00 1760.00 8448.00
* Failure costs are calculated assuming that one recording costs 220.00  (Department of Clinical
Neurophysiology, Kuopio University Hospital, 2008) and that there is a total of 200 recordings per year
per device.
6.2 Accuracy of automatic analysis of ambulatory sleep record-
ings
A significant portion of patients classified as having mild obstructive sleep apnea with
manual analysis were misdiagnosed as normal with both devices (65.4% with Venla and
11.4% Embletta) when automatic analysis was used (Table 6.4). Furthermore, there was
a trend to underestimate the severity of the disease in patients having moderate or severe
sleep apnea. However, there were some cases in which the automatic analysis
overestimated the severity of the disease (8.6% and 5.0% in mild and moderate classes,
respectively) with Embletta. This was not seen with Venla.
Table 6.4: The agreement between automatic and manual analysis in normal, mild, moderate
and severe disease with the Embletta device (N = 167) and the Venla device (N = 100, in Study
III). The automatic analysis led to misdiagnosis of a significant portion of patients. This was
especially significant with Venla.
	
	
Automatic
	
	
Normal Mild
disease
Moderate
disease
Severe
disease
Normal (%) Embletta (N=81)
Venla (N=53)
91.4
100.0
8.6
0.0
0.0
0.0
0.0
0.0
Mild disease (%) Embletta (N=44)
Venla (N=26)
11.4
65.4
88.6
34.6
0.0
0.0
0.0
0.0
Moderate disease (%) Embletta (N=20)
Venla (N=9)
0.0
0.0
15.0
77.8
80.0
22.2
5.0
0.0
Severe disease (%) Embletta (N=22)
Venla (N=12)
0.0
0.0
4.5
0.0
4.5
33.3
91.0
66.7
With Venla, the AHI values obtained using automatic analysis were significantly
lower than those obtained with manual analysis (Table 6.5). Significant differences
between automatic and manual analysis were found in the detection and classification of
central and mixed apneas. Despite the differences in the absolute values of parameters,
high correlations between manually and automatically determined AHI, ODI, and mixed
AHI were detected with both devices. However, the Bland-Altman analysis revealed a
significant trend in the difference between automatically and manually determined AHI,
ODI and mixed apnea indices in the case of Venla.
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Table 6.5: Comparison of manually and automatically analysed respiratory parameters in Study
III. With Venla, the AHI values obtained using automatic analysis were significantly lower than
those obtained with manual analysis. Especially, the automatic analysis failed in detecting
mixed and central apneas.
Venla
manual
Venla
automatic
Embletta
manual
Embletta
automatic
Whole population
AHI 12.2  21.2 8.3  17.5 * 12.5  17.3 12.5  16.6
Mixed apnea 1.5  4.3 0.1  0.2 * 1.0  3.2 0.6  2.2 *
Central apnea 0.6  1.4 0.0  0.2 * 0.5  1.4 0.5  1.5 *
Mild disease
AHI 9.1  3.1 4.7  3.1 * 9.0  2.5 9.5  3.4
Mixed apnea 0.2  0.4 0.0  0.0 * 0.5  1.2 0.3  0.9
Central apnea 0.3  0.5 0.0  0.1 * 0.5  1.2 0.3  0.6
Moderate disease
AHI 21.6  4.2 12.1  3.8 * 22.9  3.7 22.8  4.4
Mixed apnea 2.0  1.9 0.1  0.2 * 1.4  2.0 0.6  0.8 *
Central apnea 1.3  2.2 0.0  0.1 * 0.6  1.1 0.9  1.8
Severe disease
AHI 60.0  29.1 46.2  28.7 50.0  16.5 47.1  17.8
Mixed apnea 10.0  8.4 0.3  0.5 * 5.3  7.2 3.4  5.0 *
Central apnea 2.5  2.7 0.2  0.5 * 1.7  2.8 2.0  3.2
* p < 0.05 (Wilcoxon signed rank-test)
6.3 A portable device for brain function monitoring with event-
related potentials
In Study IV, a portable battery powered device for clinical auditory ERP measurements
was developed and validated. Prior to the in vivo application, extensive technical tests
and performance value measurements were conducted. The total power consumption of
the device was found to be 2.8 W (460 mA at 6.0 V), of which the data logger consumes
about half. The estimated operating time of the device with four D-size (18 Ah)
batteries is 27 hours (70% of the battery energy consumed). The radio frequency
emission generated by the device was found to be well below the limitations set by the
International Special Committee for Radio Interference.
The intensity of the audio stimulus was found to correspond accurately to the thumb
wheel setting (mean difference 0.20 ± 0.51 dB, Figure 6.3(a)). Furthermore, the sine-
wave audio tones (560 Hz and 800 Hz) were found to be free of glitches, hum and
broadband audio noise.
The input signal range (32.0 ± 0.1 mV, mean ± sd) and the bit resolution (0.489 ±
0.001 V/bit) were found to be closely matched between the four EEG channels.
Similarly, the pass bands (0.5 Hz - 85 Hz, -3 dB) of the EEG channels were found to be
identical (Figure 6.3(b)). The input signal range, bit resolution and pass band of the
ECG channel are 65.5 mV, 0.999 μV/bit and 0.8 Hz – 85 Hz, respectively. The pass
bands are shown in Figure 6.3(b), respectively. The broadband RMS noise amplitudes
of the input channels of the data logger were 2.10 ± 0.14 μV. However, the filtering (1.0
– 45.0 Hz) diminished the RMS noise amplitudes (0.80 ± 0.14 μV) significantly.
The quality of recorded spontaneous biosignals (EEG and ECG) was high, and the
recorded data suited well for the clinical applications (Figure 6.4 (a) and (d)). The ERPs
measured using an oddball paradigm with 85% standard (800 Hz) and 15% deviant (560
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Hz) stimuli produced a clearly distinguishable response to the deviant tones when
compared to the standard tones (Figure 6.4 (b)). In addition, the cortical SEP
measurements were successful in producing distinct, noise-free responses (Figure
6.4(c)). The SEP measurements showed that the detection of external triggers in the data
logger is very precise, as suggested by the high temporal accuracy of the electrical
stimulus artefact peak. Virtually no temporal jitter of the artefact peak could be detected
between individual stimuli.
Figure 6.3: The intensity of the audio stimulus was found to correspond accurately to the thumb
wheel setting (a). The pass bands (0.5 – 85 Hz, -3 dB) of the EEG channels were identical (b).
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Figure 6.4: Examples of different signals recorded with the Emma device. The quality of
recorded spontaneous EEG while awake (eyes closed) was found to be good (a). The ERPs
measured using the oddball paradigm produced a clearly distinguishable response to the
deviant tones compared to the standard tones (b). The SEP recordings were of good quality
producing distinct noise free responses (c). The quality of ECG recordings was found to be
good as demonstrated here in V4 derivation of the 12-channel system (d).
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Discussion
7.1 Novel low-cost ambulatory devices for screening of sleep
apnea
It has been estimated that 9 - 24% of the middle-aged population suffers from
undiagnosed OSA (Young 1993, Young 1997). Since undiagnosed OSA increases
significantly the risk of many cardiovascular diseases and mortality (Wilcox 1998,
Shahar 2001, Marin 2005, Valham 2008), it is of great importance to develop an
inexpensive and straightforward means for diagnosing OSA.
In Study I, a novel 8-channel Type 3 device (Venla) for screening of OSA was
introduced. Prior to its in vivo application, the device was evaluated with extensive
technical tests and was found to meet strict electromagnetic emission limits (Williams
1996). The first part of the clinical evaluation was arranged by making 19 recordings
simultaneously with Venla and a clinical reference instrument (Embla) in a sleep
laboratory.
Similarly, in the first part of Study II, a novel ambulatory Type 3 device (APV2)
was evaluated by conducting 10 simultaneous measurements with this device and a
clinical reference instrument (Embla). Both evaluated devices (Venla and APV2)
showed similar diagnostic capabilities as the reference equipment in detecting sleep
apnea. They also showed no statistical difference to the reference device in the
evaluation of the apnea-hypopnea or oxygen desaturation indices. In addition, the AHI
and ODI values determined with the devices and the reference instrument were highly
linearly correlated.
The second part of the clinical evaluation in Study I was arranged by conducting
323 ambulatory home recordings of which 275 (193 males and 82 females) were
diagnostically acceptable. The Venla device and the commercial reference device
(Embletta) showed similar diagnostic capabilities in detecting sleep apnea. No statistical
differences were found between the devices in the estimation of the apnea-hypopnea or
oxygen desaturation indices.
Good technical reliability is a key issue for a sleep-recording device when screening
large populations, since unsuccessful recordings increase economic costs and queuing
times. In the second parts of Studies I and II, the clinical home recordings of Venla (N =
106), APV2 (N = 149) and Embletta (N = 169) were evaluated by comparing the
diagnostic quality of recordings. The result was that 89.1, 90.0 and 77.2% of the
recordings were technically perfect, 93.3, 96.0 and 80.8% were diagnostically
acceptable and 6.7, 4.0 and 19.2% totally failed with Venla, APV2 and Embletta,
respectively. The results indicate that APV2 and Venla are technically more reliable
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than Embletta, a device which is widely used in sleep apnea diagnostics. Furthermore,
when compared to the percentage of successful recording (76.6 – 94.4%) reported in the
literature for current commercial devices (Whittle 1997, Portier 2000, Lloberes 2001,
Gagnadoux 2002, Dingli 2003), the novel devices demonstrated good technical
reliability.
The technical reliability of the recording depends on the transducers used. The ease
of use is especially important, since in many cases the patient must be able to operate
the equipment by themselves without technical support. Usually patients see the
equipment and transducers for the first (and probably the last) time in their life and must
attach the transducers to themselves according to written instructions. Thus, the
transducers must be easy to attach and they must stay firmly in place regardless of
movements throughout the night. For these practical reasons an oronasal thermistor and
strain gauge respiration movement sensors were chosen for incorporation into the Venla
device.
In addition, there is very limited possibilities to confirm that the transducer is
working properly when it is set in its place. For example, when the oxygen saturation
transducer is set, there is no way to confirm that it is working properly unless there is a
digital display to show the saturation and pulse signals. Venla and APV2 both contain
an LCD screen to help to confirm that the oxymeter is working properly. For the real
time verification of airflow and respiration movements, there is a coarse graphical
display of the signals on the LCD. Furthermore, the display showing the status of the
transducers is handy when the transducers are cleaned and checked after recording,
since mechanical or electronic problems can be immediately confirmed and corrected.
Several studies have shown that a nasal pressure cannula is a better transducer for
detecting hypopneas than a thermistor (Norman 1997, Ballester 1998, Series 1999,
Hernandez 2001, Teichtahl 2003, BaHammam 2004). This follows from the fact that the
square root of the differential pressure derives directly the volume flow rate, (Equation
(10) in Chapter 2.4.2). In contrast, a thermistor will produce a flat signal, regardless of
airflow, if the temperature of exhaled airflow is same as the ambient temperature.
Furthermore, it must be noted that a thermistor records the time derivative of the
airflow. However, a nasal cannula cannot record mouth breathing (Farre 2004). For this
reason, Venla was equipped with an additional thermistor channel. In practice, a nasal
cannula may sometimes irritate the sensitive skin around and inside the nostrils and the
patient may remove it during the night. Thus, the additional thermistor may sometimes
rescue the whole recording.
Venla and especially its successor, APV2, have been designed to be as simple and
robust as possible to enable the operation of the devices with minimal or no training.
Moreover, since the recorded data are stored in a relatively small file (5 MB) in an
encrypted format without any confidential patient information, the file may be safely e-
mailed to the specialist sleep physician for analysis. These features, together with good
technical durability and reliability, make the evaluated devices idelally suited for
telemedical screening of OSA.
Both evaluated recording devices, Venla and APV2, are intended for recording adult
people with suspected sleep apnea. They are not recommended for use with children or
with some complicated special patients.
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7.2 Automatic analysis of ambulatory recordings
In Study III, the recordings made in Study I were re-analysed automatically with widely
used commercial analysis software (Somnologica 3.2). The aim was to evaluate the
agreement between manual and automatic analysis in Venla and Embletta recordings.
Significant differences in detection and classification of the severity of OSA were
detected between the devices (Venla versus Embletta) when automatic analysis was
used. However, manual analysis of the same data as in Study I detected no statistical
difference between the devices. The results are in line with the current clinical
guidelines for diagnosis of OSA (Collop 2007). The guidelines recommend a review of
the raw data by a certified sleep specialist and manual scoring or manual editing of the
automated scoring results by skilled personnel. The reliability of automated analysis has
been criticised in several studies (Carrasco 1996, Cirignotta 2001, Fietze 2002, Yin
2005). However, the suitability of using analysis software with different recording
devices has not been previously investigated. Many clinics use several different devices
and analysis software. The possibility to use only one type of analysis software is
tempting as it could bring significant economical and practical advantages. It might also
allow the use of low-cost monitoring devices without the need to purchase expensive
instrumentation-specific software.
In Study III, automatic analysis proposed a false negative diagnosis in a significant
portion of patients having mild obstructive sleep apnea (65.4% with Venla and 11.4%
with Embletta). In addition, the same trend of classification into a milder class was seen
in patients with moderate and severe disease. The unreliability of diagnosing the mild
disease with automatic analysis is a very important finding because mild OSA
represents the most prevalent subgroup of OSA patients. This is especially important
since the treatment of OSA can prevent its progression and the initiation of harmful
cardiovascular consequences (Buchner 2007, Sahlman 2007).
When similar transducers were evaluated for measurement of airflow and oxygen
saturation in Venla and Embletta only minor technical differences were determined
between the biosignals recorded with these devices. However, in Study III significant
differences were discovered in the reliability of automated analysis of these signals.
This indicates that even minor variations in the signal properties can alter the reliability
of automated analysis. It is known that the technical quality of the ambulatory
recordings varies significantly due to practical problems (Golpe 2002, Dingli 2003,
Reichert 2003, Yin 2006). In Study III, the most common reasons for technical failures
and for the exclusion of the recording from the study were loss of either airflow or
oxygen saturation signals.
The main differences in the signal acquisition with Venla and Embletta are the
sampling frequencies of the nasal pressure (8 versus 20 Hz), the oxygen saturation (1
versus 3 Hz), the thorax and abdomen movements (8 versus 10 Hz) and the body
position (8 versus 10 Hz) signals. These differences may have contributed to the
differences in the accuracy of the results of the automatic analysis.
Automatic and manual analyses were found to differ significantly in the sensitivity
of detection of sleep apnea and in the classification of mixed and central apneas. This is
an important finding as even though automatic detection of mixed and central apneas is
commonly included in the analyses, its reliability has not been thoroughly investigated.
This is a clinically relevant issue, because large numbers of mixed and central events
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are indicative of a more severe form of OSA, and misclassifications of these events may
significantly delay the treatment of the patient.
The present findings are important because several ambulatory monitoring systems
have been developed in order to optimize cost-effective screening of OSA. The
automated analysis of the signals is widely applied since it is simple to perform, saves
time and resources and is reliable in most cases. However, the present results show that
the exclusion of OSA should never be based on automated analysis alone. The diagnosis
of mild OSA should always be based on manual analysis of recordings, but if the
automatic analysis points to moderate or severe obstructive disease, the suggestion may
be accepted without further manual confirmation of the validity of the analysis. It is
important that the classification of the type of the apnea further to obstructive, mixed or
central type should always be done manually.
7.3 Applicability of the novel portable ERP device for brain
function monitoring
In Study IV, a compact portable battery operated device for ERP, SEP, EEG and ECG
measurements was designed, constructed and programmed for off-line monitoring of the
level of consciousness or depth of sedation. The device is intended to be used in
intensive care units and emergency rooms, which places special requirements for the
robustness and ease of use of the instrumentation.
In the technical evaluation, the RMS noise amplitudes for the EEG and ECG
channels were found to be at an acceptable level. Even though the RMS noise of the
non-filtered signal (2.1 μV) exceeds the recommended maximum (0.5 μV) (Nuwer
1998), one can obtain high quality clinical EEG measurements with this device
(Westeren-Punnonen 2005). The ERP measurements are based on averaging of
hundreds of individual events which effectively reduces the RMS noise and improves
the signal quality compared to spontaneous EEG. Band pass filtering reduces the RMS
noise even further.
Modern equipment must not disturb or be disturbed by the other medical
instruments. This is especially important with monitoring and life supporting
equipment, which must fulfil the requirements of the International Special Committee
for Radio Interference (CISPR 11 EN 55 011) (Williams 1996). For this reason, the
Emma device was constructed to minimize spurious electromagnetic emission, even
though this meant some compromises which slightly reduced its performance. In
extensive EMC testing (Pohjois-Savo Polytechnic, Kuopio, Finland), the device was
found to meet the strict emission limitations. The device was designed to be battery
operated to help to minimize electromagnetic noise and to enhance electric safety. The
estimated operating time of the device is 27 hours, which is well suited for clinically
typical 24-hour monitoring periods in the ICU.
In addition to high quality of recorded EEG, the quality of the stimulus is very
important in ERP recordings. The audio stimulus intensity was found to correspond
accurately to the thumb wheel setting (Figure 6.3). In addition, the stimulus tones were
found to be free of any imperfections such as glitches, hum or broadband audio noise.
This is important, because it is known that the audio stimulus intensity has a significant
effect on the ERP responses (Adler 1989). In addition, the audio stimulus imperfections
can distort the ERP responses and, thus, reduce the reliability of clinical measurements.
Kuopio University Publications C. Natural and Environmental Sciences 261: 1 - 79 (2009)
- 67 -
7 Discussion
In addition to the technical tests, the device was successfully evaluated in the clinic.
The oddball paradigm with 85% standard (800 Hz) and 15% target (560 Hz) stimuli
produced a clearly distinguishable ERP response (P300) to the target tones compared to
the standard tones. In addition to ERP measurements, it was possible to undertake
cortical SEP measurements producing distinct, artefact free responses (N19 and P22).
Additionally, the sharp stimulus artefact spikes just after the stimulus event indicate that
the external event marking mechanism in the data acquisition section is precise.
In addition to the technical and preliminary clinical tests with healthy volunteers
included in Study IV, several clinical studies have been carried out with the device
(Yppärilä 2002a, Yppärilä 2002b, Haenggi 2004, Yppärilä 2004a, Yppärilä 2004b,
Westeren-Punnonen 2005). In these studies, the depths of sedation in adult patients
under-going open-heart surgery (Yppärila 2002a) and sedation-induced changes in the
EEG in children with adenoidectomy (Nieminen 2002) have been investigated. In
addition, the device has been used for estimation of the effect of propofol sedation on
ERPs and EEG in intensive care patients (Yppärila 2004b). In these studies,
electromagnetic interference from other medical devices in ICU has been found to be
relatively low and not to impair the clinical quality of the measurements.
In a case study of a patient suffering from an episode of postoperative ventricular
fibrillation (Westeren-Punnonen 2005), the auditory ERPs recorded with Emma were
found to recover faster than the EEG after the ventricular fibrillation and cardiac arrest.
The N100 component recovered to the baseline level within six hours after successful
resuscitation, while the EEG still showed very slow and low-amplitude background
activity. This is a clinically important finding, suggesting that devices like Emma can be
of great benefit in the early prognostic assessment after different kinds of central
nervous system insults.
The clinical applicability of Emma has been demonstrated in various clinical
studies. However, the lack of a display and real-time signal processing enabling
instantaneous evaluation of the status of the patient is the most evident shortcoming of
the device. Moreover, recording of additional physiological parameters such as oxygen
saturation, breathing movements and air flow would enable more comprehensive
evaluation of central nervous system functions.
7.4 On the development of devices for clinical use in a hospital
environment
Clinical diagnostic devices are generally developed in research institutes and
commercial companies. Although the developers strive to listen to the needs of the end
users, many features of the devices are often not optimal for economic diagnostics.
Often the devices provide many diagnostically irrelevant features making them
complicated and expensive. The interests of companies (profits) and hospitals
(diagnosis and treatment of patients) rarely intersect. For example, the business consept
of a manufacturer may be based on the maintenance of fragile devices and selling of
expensive spare parts. The low durability and reliability of portable sleep monitors may
be an example of these dubious commercial tactics. However, by searching for solutions
from the user’s point of view, new ideas can arise.
Furthermore, commercial devices may be too complicated to use as they are often
designed from engineers’ point of view. This can lead to failed recordings due to human
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errors. The main goal of this work was to build robust, reliable, and easy to use devices.
Device development inside a hospital provides immediate connection to the end users,
and the feedback is instant and honest. In hospitals, new ideas and devices (for example
transducers) can be applied and clinically tested, because the appropriate reference
instruments are readily available.
However, developing novel devices inside a hospital clinic is challenging.
Economics may have a significant role because the development of devices does entail
some costs. Hospital organizations may have strict limitations and rules that can totally
block this kind of work and prejudice attitudes can lead to serious limitations. Many
influential administrators may believe that a hospital is for treating patients, not for
scientific work or device development.
However, Studies I and IV reveal that development of devices or methods for
clinical use can be conducted in a hospital environment and lead not only to scientific
findings but also to commercial opportunities.
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CHAPTER VIII
Summary and conclusions
In this work, novel devices were designed, constructed and evaluated for use in the
clinical diagnostics of sleep apnea and for monitoring of the depth of sedation or the
level of consciousness.
1. The device developed in the Study I demonstrated similar diagnostic capabilities
in the detection of sleep apnea as a commercial reference device. No statistical
differences were found between the devices in evaluating the apnea hypopnea or
in oxygen desaturation indices. Both the AHI and ODI values determined with the
novel device and the reference instrument were highly linearly correlated. The
developed device showed good technical reliability compared to devices evaluated
in the literature.
2. The portable seven-channel recording device evaluated in Study II proved to be as
good as the commercial reference device in detecting sleep apnea. No statistical
differences were found in AHI or ODI values determined from simultaneous
recordings with the reference instrument and the novel device. However, the
technical reliability of the novel device was found to be superior to the values
reported for other devices in the literature.
3. The reliability of automatic analysis of breathing events was found to be critically
dependent on signal quality and therefore on the recording device. The
comparison of automatic and manual analysis of ambulatory recordings of
nocturnal breathing disorders revealed that an exclusion of obstructive sleep apnea
should not be done based on automated analysis alone. However, automated
analysis can greatly assist in the manual analysis, especially in severe cases.
Importantly, automatic analysis was found to fail in the detection of mixed and
central apneas and those events should always be checked manually.
4. The device developed in Study IV was found to be suitable for safe and reliable
measurement of ERP, EEG, and SEP. To our knowledge, no other portable
instrument capable of ERP recordings in intensive care units has been described in
the literature.
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